KR20080098193A - Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract - Google Patents

Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract Download PDF

Info

Publication number
KR20080098193A
KR20080098193A KR1020070043556A KR20070043556A KR20080098193A KR 20080098193 A KR20080098193 A KR 20080098193A KR 1020070043556 A KR1020070043556 A KR 1020070043556A KR 20070043556 A KR20070043556 A KR 20070043556A KR 20080098193 A KR20080098193 A KR 20080098193A
Authority
KR
South Korea
Prior art keywords
extract
group
alcohol
saengmaeksan
tofu
Prior art date
Application number
KR1020070043556A
Other languages
Korean (ko)
Inventor
박갑주
이형환
김강성
권혁한
Original Assignee
박갑주
권혁한
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박갑주, 권혁한 filed Critical 박갑주
Priority to KR1020070043556A priority Critical patent/KR20080098193A/en
Publication of KR20080098193A publication Critical patent/KR20080098193A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07Soya beans, e.g. oil-extracted soya bean flakes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A23L2/04Extraction of juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Saengmaeksan(Oriental medicine therapy) extracts is provided to reduce the blood alcohol concentration and The lipid concentration of the neutral and blood cholesterol by being extracted from snake's beard, Maximowiczia typical, ginseng, pumpkin and hedysarum. A bean curd by using Saengmaeksan(Oriental medicine therapy) extracts comprises the following steps. Snake's beard 2.6-5.0%, Maximowiczia typical 2.6-5.0%, ginseng 1.0-5.0%,, pumpkin 2.6-5.0% and hedysarum 2.6-5.0% are mixed as the rate of weight% and Concentrate is extracted by heating at 95-130deg.C for 2-5 hours in the pot for preparing medicine and filters to the gauze and centrifuges at the speed of 5000~8000 X g for 10-30min. to make Saengmaeksan(Oriental medicine therapy) extracts. soy oil 95-97%(v/v) consisting of bean is mixed with the Saengmaeksan(Oriental medicine therapy) extracts3 ~ 5%(v/v).

Description

생맥산 추출물 및 그 추출물을 이용한 생맥산 두부{saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract}Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract}

도 1은 실험동물 Sprague-Dawley(수컷)의 시료 투여 후 4주 동안의 성장과 체중변화량을 측정한 평균체중 증가율 결과를 나타낸 것이다.Figure 1 shows the results of the average weight increase rate measured the amount of growth and weight change for 4 weeks after the administration of the sample of the animal Sprague-Dawley (male).

도 2는 실험동물 Sprague-Dawley(수컷)의 시료 투여 후 4주 동안의 성장과 체중변화량을 측정한 총 체중 변화량 결과를 나타낸 것이다.Figure 2 shows the results of the total weight change measured the growth and weight change for 4 weeks after the administration of the sample of the animal Sprague-Dawley (male).

도 3은 생맥산 추출물의 체내 젖산가수분해효과를 나타낸 것이다.Figure 3 shows the lactic acid hydrolysis effect of the raw mach acid extract in the body.

도 4는 생맥산 추출물의 체내 알코올 분해효과를 나타낸 것이다.Figure 4 shows the alcohol degradation effect of the body extract of draft malt.

도 5는 혈장 내 트리글리세라이드 함량을 나타낸 것이다.Figure 5 shows the triglyceride content in plasma.

도 6은 혈장 내 콜레스테롤 함량을 나타낸 것이다.Figure 6 shows the cholesterol content in plasma.

도 7은 일반두부 투여군(T1), 생맥산 두부 투여군(T2) 및 생맥산 추출물 투여군(T3)의 간 보호활성효과를 알아보기 위해 4주 간 시료 투여 후 혈장 AST 수치의 변화를 나타낸 것이다.Figure 7 shows the change in plasma AST levels after administration of the sample for 4 weeks to determine the hepatoprotective effect of the general tofu administration group (T1), live maize tofu administration group (T2), and the raw maw extract extract group (T3).

도 8은 일반두부 투여군(T1), 생맥산 두부 투여군(T2) 및 생맥산 추출물 투여군(T3)의 간 보호활성효과를 알아보기 위해 4주 간 시료 투여 후 혈장 ALT 수치의 변화를 나타낸 것이다.Figure 8 shows the change in plasma ALT levels after administration of the sample for 4 weeks to determine the hepatoprotective effect of the normal tofu administration group (T1), live maize tofu administration group (T2) and the raw maize extract administration group (T3).

도 9는 생맥산 두부의 항 산화효과를 나타낸 것이다.Figure 9 shows the antioxidant effect of the draft tofu.

본 발명은 각각 중량비율로 하여 맥문동 2.6 내지 5.0%, 오미자 2.6 내지 5.0%, 황기 2.6 내지 5.0%, 인삼 1.0 내지 5.0%, 호박 2.6 내지 5.0%와 증류수 75 내지 87%를 혼합하여 2 내지 5시간 동안 95 내지 130℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 5000∼8000×g의 속도로 10∼30분간 원심분리하여 추출하는 것을 특징으로 하는 생맥산 추출물에 관한 것이다.In the present invention, by weight ratio of 2.5 to 5.0%, Schisandra chinensis 2.6 to 5.0%, Astragalus 2.6 to 5.0%, Ginseng 1.0 to 5.0%, Pumpkin 2.6 to 5.0% and distilled water 75 to 87% by mixing for 2 to 5 hours Extracted from the concentrated solution by heating in a bath at a temperature of 95 to 130 ℃, filtered with gauze, centrifuged in a centrifuge at a rate of 5000 to 8000 × g for 10 to 30 minutes to extract the raw malic acid extract will be.

또한, 각각 중량비율로 하여 맥문동 2.6 내지 5.0%, 오미자 2.6 내지 5.0%, 황기 2.6 내지 5.0%, 인삼 1.0 내지 5.0%, 호박 2.6 내지 5.0%와 증류수 75 내지 87%를 혼합하여 2 내지 5시간 동안 95 내지 130℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 5000∼8000×g의 속도로 10∼30분간 원심분리하여 생맥산 추출물을 추출한 후, 콩으로 이루어진 10%(v/v) 두유액 95 ~ 97%(v/v)에 상기 생맥산 추출물을 3 ∼ 5%(v/v) 혼합하여 제조되는 것을 특징으로 하는 생맥산 추출물 및 그 추출물을 이용한 생맥산 두부에 관한 것이다.In addition, respectively, by weight ratio 2.6 to 5.0%, Schisandra chinensis 2.6 to 5.0%, Astragalus 2.6 to 5.0%, Ginseng 1.0 to 5.0%, pumpkin 2.6 to 5.0% and distilled water 75 to 87% for 2 to 5 hours The concentrated liquid was extracted by heating in a shaker at a temperature of 95 to 130 ° C., filtered with gauze, and centrifuged at a speed of 5000 to 8000 × g for 10 to 30 minutes to extract raw maize extract, followed by 10% of soybeans. (v / v) The present invention relates to the raw machinate extract and tofu using the extract, characterized in that it is prepared by mixing the 3 to 5% (v / v) of the raw malic acid extract in soymilk 95-97% (v / v). .

본 발명의 생맥산 추출물 및 그 추출물을 이용한 생맥산 두부에서 사용한 한약재는 생맥산이라고 알려져 있는 약재로써 동의보감을 비롯한 전통의학서에 보혈, 양혈하며, 폐음허(肺陰許)로 인한 권태무력(捲怠無力)·호흡곤란·현기증·해수·열감(熱感) 등의 치료 기능을갖는 대표적인 처방으로 기록된 약으로 이의 구성약재 는 맥문동, 오미자, 인삼 및 황기이다. 상기와 같은 약재가 혼합된 생맥산(生脈散)은 내외상판혹론(內外傷辦惑論)에 따르면 맥문동(麥門冬) 12g 인삼(人蔘) 6g 오미자(五味子) 5g으로 구성된 것으로 적응증(適應症)으로 폐음허(肺陰許)로 인한 권태무력(捲怠無力)·호흡곤란·현기증·해수·열감(熱感) 등에 사용되고 효능은 익기생진(益氣生津)하고 렴음지한(斂陰 止汗)하는 효능이 있다. 주치는 기음부족(氣陰不足)으로 인한 체권기단나언(體倦氣短懶言), 구갈다한(口渴多汗), 인건설조(咽乾舌燥),하고 맥(脈)이 허약(虛弱)한 증상(症狀)과 구해(久咳)에 의한 상폐(傷肺)로 기음(氣陰)이 양상(兩傷)되어 나타나는 건해다기(乾咳短氣), 자해(自咳)등의 증상(症狀)을 치료한다. 본 발명에서는 상기 생맥산에 호박을 가미하여 추출물을 제조하고 이를 두부응고제로 사용하여 생맥산 두부를 제조하였다.The extract of the present invention and the herbal medicine used in the raw tofu mountain using the extract is a medicine known as the raw malic acid, blood, blood donation in the traditional medicine, including Dongbogam, blood, and boredom 인한 (음 無力) It is recorded as a typical prescription that has therapeutic functions such as dyspnea, dizziness, sea water, and heat sensation. Its constituents are Megmun-dong, Schisandra chinensis, Ginseng and Astragalus. According to the internal and external wound plate theory, the raw malt mixed with the above-mentioned herbs is composed of 12g of Macmundong and 6g of ginseng and 5g of Schisandra chinensis. 사용되고) It is used for boredom, respiratory distress, dizziness, seawater, heat sensation due to lung tone, and its effect is ripe and cold. ) Has the effect of. The chief physician is weak in his clan, or clumsy, in construction, due to lack of cough. Symptoms such as dysphagia and self-injury, which are caused by coughing due to a symptom and dysfunction due to injury. Cure). In the present invention, the extract was prepared by adding zucchini to the draft malt, and this was used as a tofu coagulant to prepare the draft tofu.

본 발명의 생맥산 추출물 및 그 추출물을 이용한 생맥산 두부에서 두부응고제로 사용된 생맥산 추출물의 주요 구성분인 맥문동을 비롯한 한약재는 경동시장에서 구입하였고 맥문동, 오미자, 황기, 호박의 학명 및 주치, 적응증은 하기와 같다. 맥문동 (麥門冬)은 백합과(덤불란科)에 속하며 학명은 치계초(治階草) Ophiopogon japonicus KER-GAWLER[소엽맥문동(小葉麥門冬)]이며 괴근(槐根)의 건조품으로써 포도당, 점액질, 소량의 β-시토스테롤, 비타민 A모양의 물질이 함유되어 있고 윤조생진(潤燥生津), 화담지해(化痰止咳)하다고 알려져 있다. 기원은 백합과 식물인 지계초의 괴근을 건조한 것으로 효능은 양음윤조(養陰潤燥), 생진지해(生津止咳)하고 주치(主治)는 폐조건해(肺燥乾咳), 토혈(吐血), 객혈(喀血), 폐 (肺), 폐옹(肺癰), 열건구조(咽乾口燥), 허로번열(虛勞煩熱)등에 사용되며, 약리 실험에 서 강심작용, 이뇨작용, 가래삭힘작용, 기침멎이작용, 영양작용, 억균작용 등이 밝혀졌다.The medicinal herb extract of the present invention and the medicinal herbs including McMun-Dong, which is the main component of the raw MIC extract used as a tofu coagulant in tofu coagulant tofu, were purchased from Kyungdong Market. Same as Macmun-dong belongs to the family Liliaceae, and its scientific name is Ophiopogon japonicus KER-GAWLER. It contains mucus, small amounts of β-sitosterol and vitamin A-like substances, and is said to be yunjosaeng (화 生 津) and haematjihaeji (化痰止咳). Its origin is dried roots of lichen plant Jigyecho, its efficacy is Yin-Yum Yun-Jung, Saengjin-Jeong-Jeong, and the chief physician is pulmonary condition, soil, blood and hemoptysis. (喀 血), lung (肺), lung 肺 癰 (열 口), heat-drying structure (허 口燥), it is used for gynecological heat, etc. In pharmacological experiments strong cardiac effect, diuretic effect, sputum cutting effect, cough Whining, nutrition, fungi has been found.

오미자(五味子)는 오미자과에 속하며 학명이 북오미자(北五味子) Schizandra chinensis BALL.(오미자)이며 성숙과실의 건조품으로 시트랄(citral) 등의 정유, 스치잔드린(schizandrin), 비타민 A 모양의 물질, 비타민 C, 유기산, 에테르 추출물(抽出物)에 각종 약리(藥理)가 인정되어 있다. 렴폐자신(斂肺滋腎), 생진렴두, 삽정지사(澁精止瀉)하며 중추신경계흥분(中樞神經系興奮), 진해담(鎭咳 痰), 자궁흥분(子宮興奮), 항균(抗菌), 트랜스아미나제(Transaminase) 강하작용(降下作用)이 인정되고 폐신양허(肺腎陽虛)에 사용된다. 본 품은 오미(五味)를 고루 갖추고 있는데, 특히 산(酸)·미(味)가 탁월하므로 소모된 폐기(肺氣)를 수렴(收斂)하여 익기생진(益氣生津)하고, 아울러 익신기(益腎氣)하여 진원(眞元)을 고섭(固攝)한다. 그 성질이 따뜻하되 건조하지 않아 폐신(肺腎)의 음허(陰虛)와 양허(陽虛)를 막론하고 모두 사용할 수 있다. 일반적으로 폐허(肺虛)로 인한 천해(喘咳), 자한(自汗), 도한(盜汗), 신허(腎虛)로 인한 골정(骨精), 구사불지(久瀉不止) 등을 치료하는 데 사용하며, 약리실험에서 중추신경계통흥분작용, 피로회복촉진작용, 심혈관계기능회복작용, 혈압조절작용, 위액분비조절작용, 혈당량낮춤작용, 글리코겐증진작용 등이 밝혀졌다.Schizandra chinensis BALL. (Schisandra chinensis BALL.) Is a dried fruit of mature fruit, schizandrin, vitamin A-shaped substance. , Vitamin C, organic acids, ether extracts (抽出 物) has been recognized various pharmacology (藥理). Pneumonia Self-Contained, Raw Pulmonary Dome, Insertion Branch, Central Nervous System Excited, Jinhaedam, Uterine Excited, Antibacterial ), Transaminase lowering action (降下 作用) is recognized and used in lung Xinyangheo (肺 腎陽虛). This product is equipped with Omi, especially since it is excellent in acid and rice, it collects and discards used wastes and ripens.益腎 氣) to confound the circle (진 元). It is warm in nature but not dry, so it can be used regardless of yin huo (폐) and Yang (() of the lung. In general, it is used to treat shallowing due to ruins, self-limiting, self-limiting, limiting, bone tingling caused by new license, and inability to speak. In pharmacological experiments, central nervous system excitement, fatigue recovery, cardiovascular function recovery, blood pressure control, gastric juice secretion, blood glucose lowering, glycogen-promoting, etc. were found.

인삼(人蔘)은 오갈피나무과에 속하며 인삼(人蔘) Panax ginseng G.A.MEY.(인삼)의 근(根)의 건조품으로서 파나센(panacene), 파나퀼론(panaquilon), 파나신 (panaxin), 진세닌(ginsenin), 인삼산(人蔘酸), 비타민 A, B1, B2, C, 자당, 포도 당, 과당, 맥아당, 초인(choine), 무기염, 고미질(苦味質), 점액(粘液)등을 함유하고 있으며 대보원기(大補元氣), 안신익지(安神益智), 건비익기(健脾益氣), 생진(生津)하며 신경계흥분(神經系興奮), 부신피질기능흥분(副腎皮質機能興奮), 성선자극(性腺刺戟)호르몬 모양의 작용, 강심, 혈당강하(血糖降下), 소화흡수와 신진대사 항진(亢進), 항이뇨(抗利尿), 항과민증(Anaphylaxis)등에 작용한다. 주로 급성 쇼크와 만성쇠약자에게 사용한다.Panax ginseng is a dried product of the root of Panax ginseng GAMEY. Ginseng Panacene, panaquilon, panaxin, and ginseng. Ginseng, Ginseng, Vitamin A, B1, B2, C, Sucrose, Glucose, Fructose, Malt Sugar, Choine, Inorganic Salt, Glutinous, Mucus Daebowongi, Anshin-ikji, Geunbi-ikgi, Geunjin-jin, nervous system excitement, adrenal cortex excitement Mechanism, gonadotropin-like action, cardiac, hypoglycemic, digestive absorption and metabolic hyperactivity, antidiuresis, anaphylaxis, etc. It is mainly used for acute shock and chronic weakness.

황기(黃耆)는 콩과에 속하며 Astragalus membranaceus BUNGE.(황기)의 뿌리의 건조품으로 염산, 코린(corin), 아미노산 등을 함유하고 있으며 보기승양 (補氣升 陽), 탁독배농(托毒排膿)하다. 본품은 기허(氣虛)를 치료하는 요약(要藥)으로 알려져 있으며 기허불함(氣虛不陷)인 경우에 사용하면 보기승양(補氣升陽)하고, 표허불고(表虛不固)인 경우에 사용하면 고표지한(固表止汗)하며, 기혈부족(氣血不足)에 사용하면 익기생혈(益氣生血)하며, 기허부종(氣虛不腫)에 사용하면 온양이수(溫陽利水)하고, 기허혈비(氣虛血痺)에 사용하면 온경화혈(溫經和血)한다. 호로(葫蘆)는 박과에 속하며 Lagenaria siceraria(MOLINA.) STANDL.(밤나무꽃)의 과실(호롱박)로써 포도당, 펜토산 등을 함유하고 있고 이수(利水), 해열(解熱, 거습소종( 濕消腫)에 사용하며, 약리실험에서 강장작용, 면역기능조절작용, 강심작용, 이뇨작용, 혈압낮춤작용, 항염증작용 등이 밝혀졌다.Astragalus belongs to the legumes and is the dried product of the root of Astragalus membranaceus BUNGE. (Hwanggi), which contains hydrochloric acid, corin, amino acids, etc. ) This product is known as a summary to treat vain, and when used in the case of vain embarrassment, it can be seen as an elevation, and in the case of a sign blotting. If you use it, it is highly labeled. (부 表 止汗), if you use it for deficiency of Gibgi. If you use it for gastrointestinal bleeding (氣虛 血 痺), it is a hot hardening blood (溫 經 和 血). Horo is a fruit of Lagenaria siceraria (MOLINA.) STANDL. (Chestnut flower), which contains glucose, pentosan, etc., and dihydrate, antipyretic, hygroscopic species. 사용) used in pharmacological experiments, tonic action, immune function control action, cardiac action, diuretic action, blood pressure lowering action, anti-inflammatory action was found.

호박은 박과에 속하며 학명으로는 Cucurbita spp이고, 동의보감에 보면 호박은 맛이 달고, 오장을 편하게 하고, 눈을 밝게 하는 효능이 있다고 기록되어 있다. 그리고 널리 알려진 효능으로는 출산 뒤 부기를 빼주고, 당뇨병과 불면증에 효과가 있다. 늙은 호박은 잘 익을수록 당분이 늘어나 단맛이 증가하는데 호박이 가지고 있는 당분은 소화 흡수가 잘되기 때문에 위장이 약한 사람이나 회복기의 환자에게 아주 좋고, 성인병, 부종, 설사, 기침, 감기, 야맹증, 중풍예방에 좋으며, 호박에 많이 들어있는 카로틴은 체내에 들어가면 비타민 A의 효력을 나타내는데 비타민 A는 점막을 튼튼하게 하여 감기에 대한 저항력을 길러주는 역할을 한다. 또한 미네랄과 비타민 B, 비타민 C도 풍부해 신진대사와 면역력을 좋게 하고 몸을 따뜻하게 해주므로 냉증이 있는 여성에게 좋고, 황색의 야채에는 항 산화 물질인 베타카로틴이 들어 있어 폐암, 식도암, 위암, 방광암, 후두암, 전립선암 등 여러 종류의 암을 예방하는데 늙은 호박에 이 성분이 다량 함유되어 있어 장내 바이러스와 발암물질의 활성화를 억제하는 효능이 있다.Zucchini belongs to the family of cucurbits, scientific name Cucurbita spp, and according to the synonym of the pumpkin, it is recorded that the taste is sweet, and it has the effect of relaxing five chapters and brightening eyes. And the well-known benefits of swelling after giving birth, diabetes and insomnia are effective. The older the pumpkin, the sweeter the sugar increases as it ripens. But the sugar that pumpkin has is good for digestion and absorption, so it is very good for people with weak stomachs or patients with recovery periods. Adult disease, edema, diarrhea, cough, cold, night blindness, and stroke It is good for prevention, carotene contained in the pumpkin shows the effect of vitamin A when it enters the body, vitamin A plays a role in strengthening the mucous membrane to increase the resistance to colds. In addition, it is rich in minerals, vitamin B and vitamin C. It is good for women with coldness because it improves metabolism and immunity and warms the body. Yellow vegetables contain antioxidant beta-carotene, lung cancer, esophageal cancer, stomach cancer and bladder cancer. , Laryngeal cancer, prostate cancer, etc. It is effective in inhibiting intestinal viruses and carcinogens because it contains a large amount of this ingredient in old pumpkin.

본 발명은 맥문동, 오미자, 인삼, 황기, 호박 등의 한약재를 복합하여 추출한 생맥산 추출물이 젖산가수분해효소로 항 피로효과를 나타낼 수 있으며, 혈중알코올농도를 현저히 감소시키는 알코올 분해효과가 있을 뿐만 아니라 이 생맥산 추출물로 응고시킨 두부가 고혈압이나 동맥경화증 등 심혈관계 질환 유발의 주요인자로 작용하는 혈중 콜레스테롤과 중성지방의 농도를 낮추는 것을 알 수 있으며 장기 투여하였을 때 간기능 장애의 회복기능 및 각종 성인병과 노화를 방지하는 항 산화 작용이 생맥산 추출물을 단독으로 투여했을 때보다 현저히 증가함을 알 수 있으며 이와같은 효과를 나타낼 수 있는 약품과 기능성 물질 개발에 세계적으로 많은 연구와 노력이 진행되고 있으며 특히 인체에 부작용이 적은 천연물로부터 위의 약재, 또는 기능성 물질을 개발할 수 있으며 신규의 항 피로효과와 알코올 분해효과 및 항 고지혈증 효과, 간기능활성증진 및 항 산화제로서 개발할 수 있는 생맥산 추출물 및 그 추출물을 이용한 생맥산 두부의 제공을 그 목적으로 한다.The present invention may be produced by extracting a mixture of medicinal herbs such as Macmundong, Schisandra chinensis, ginseng, Astragalus, pumpkin, etc., the raw malt extract may exhibit anti-fatigue effect as lactic acid hydrolase, and not only has an alcohol-degrading effect that significantly reduces blood alcohol concentration. The tofu coagulated with raw malic acid extract lowers the concentrations of blood cholesterol and triglycerides, which are the main factors inducing cardiovascular diseases such as hypertension or arteriosclerosis. It can be seen that the antioxidant activity to prevent the increase is significantly higher than when administered the raw malic acid extract alone, and many researches and efforts are underway in the development of drugs and functional substances that can exhibit such effects, especially in the human body The above medicine, or functional water from a few natural products To develop and to the anti-fatigue effect of the new and alcoholysis effect and anti-hyperlipemia effect and the extract saengmaeksan saengmaeksan head provided with the extract to develop a liver function activity and anti-oxidant for that purpose.

상기와 같은 목적을 달성하기 위한 본 발명은 각각 중량비율로 하여 맥동문 2.6 내지 5.0%, 오미자 2.6 내지 5.0%, 황기 2.6 내지 5.0%, 인삼 1.0 내지 5.0%, 호박 2.6 내지 5.0%와 증류수 75 내지 87%를 혼합하여 2 내지 5시간 동안 95 내지 130℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 5000∼8000×g의 속도로 10∼30분간 원심분리하여 추출하는 생맥산 추출물을 제공한다.The present invention for achieving the above object is by weight ratio of pulsatile 2.6 to 5.0%, Schisandra 2.6 to 5.0%, Astragalus 2.6 to 5.0%, ginseng 1.0 to 5.0%, pumpkin 2.6 to 5.0% and distilled water 75 to 87% of the mixture was heated in a shaker at a temperature of 95 to 130 ° C. for 2 to 5 hours to extract the concentrate, filtered with gauze, and centrifuged at a speed of 5000 to 8000 × g for 10 to 30 minutes to extract the extract. It provides a raw malic acid extract.

또한, 각각 중량비율로 하여 맥문동 2.6 내지 5.0%, 오미자 2.6 내지 5.0%, 황기 2.6 내지 5.0%, 인삼 1.0 내지 5.0%, 호박 2.6 내지 5.0%와 증류수 75 내지 87%를 혼합하여 2 내지 5시간 동안 95 내지 130℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 5000∼8000×g의 속도로 10∼30분간 원심분리하여 생맥산 추출물을 추출한 후, 콩으로 이루어진 10%(v/v) 두유액 95 ~ 97%(v/v)에 상기 생맥산 추출물을 3 ∼ 5%(v/v) 혼합하여 제조되는 생맥산 추출물을 이용한 생맥산 두부를 제공한다.In addition, respectively, by weight ratio 2.6 to 5.0%, Schisandra chinensis 2.6 to 5.0%, Astragalus 2.6 to 5.0%, Ginseng 1.0 to 5.0%, pumpkin 2.6 to 5.0% and distilled water 75 to 87% for 2 to 5 hours The concentrated liquid was extracted by heating in a shaker at a temperature of 95 to 130 ° C., filtered with gauze, and centrifuged at a speed of 5000 to 8000 × g for 10 to 30 minutes to extract raw maize extract, followed by 10% of soybeans. (v / v) Soymilk 95-97% (v / v) to provide the raw maengfu tofu using the raw machinate extract prepared by mixing the 3 ~ 5% (v / v) the raw machin extract.

본 발명의 생맥산 추출물은 맥문동, 오미자, 황기, 인삼 및 호박을 혼합하여 총 300g에 증류수 1500 mL을 첨가하여 3시간 동안 약탕기(대웅약탕기)에서 추출한 후 거즈를 이용하여 1차 여과하고 8,000×g에서 15분간 원심분리하여 생맥산 추출 물을 구비하였다.The raw malt extract of the present invention is mixed with McMun-Dong, Schisandra chinensis, Astragalus, Ginseng and Zucchini, and then added 1500 mL of distilled water to a total of 300 g and extracted in a medicinal herb (Daewoong medicinal herb) for 3 hours, followed by primary filtration using gauze and at 8,000 × g. Centrifugation for 15 minutes was provided with raw malic acid extract.

또한, 생맥산 추출물을 이용한 샹맥산 두부는 맥문동, 오미자, 황기, 인삼 및 호박을 혼합하여 총 300g에 증류수 1500mL를 첨가하여 혼합하고, 3시간 동안 110℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 8,000×g의 속도로 15분간 원심분리하여 생맥산 추출물을 추출하였으며, 상기 추출된 생맥산 추출물을 4℃에 보관하여 두부응고제로 준비하였고, 공지된 10%(v/v) 두유액에 두부응고제로써 상기 생맥산 추출물을 4%(v/v) 첨가하고 양성대조군으로 20% 염화마그네슘 용액 2%(v/v)를 첨가하여 두부를 제조하였다. In addition, Shangmasan tofu using the raw malic acid extract is mixed with Mengmundong, Schisandra chinensis, Astragalus, ginseng and pumpkin, and added to the total 300g by adding 1500mL of distilled water, and heated in a bath at a temperature of 110 ℃ for 3 hours to extract the concentrate, Filtration with gauze, centrifuge at 8,000 × g for 15 minutes to extract the raw machi extract by centrifugation, the extracted machi extract was stored at 4 ℃ prepared as a tofu coagulant, 10% known (v / v 4) Tofu was prepared by adding 4% (v / v) of the said raw malic acid extract as a tofu coagulant and adding 2% (v / v) of 20% magnesium chloride solution as a positive control.

본 발명에서 사용한 생맥산 두부를 제조하기 위하여 통상적인 10%(v/v)두유액을 제조한 후 잘 저으면서 상기 시료를 40분간 끊였다. 이때 기포가 발생하면 4∼5방울의 콩기름을 첨가하였다. 상기 끊인 두유액을 거즈를 사용하여 여과한 후 두유(soybean milk)와 커드(bean curd refuse)를 분리하였다. 분리한 두유를 85~90℃까지 냉각한 후 50mL의 두유를 비커에 분주하였다. 비커에 두부응고제로써 상기에서 생맥산 추출물을 각각 3~5%(v/v) 첨가하여 혼합하였으며 양성대조군으로 20%MgCl2용액 2%(v/v)를 첨가하였으며 음성대조군으로는 증류수를 첨가하였다. 상기 두부응고제를 첨가한 시료를 실온에서 1시간 방치하여 두부를 제조하였다.In order to prepare the raw tofu used in the present invention, after preparing a conventional 10% (v / v) soymilk solution, the sample was cut for 40 minutes while stirring well. At this time, if bubbles were generated, 4-5 drops of soybean oil were added. The cut soy milk solution was filtered using gauze to separate soybean milk and curd refuse. After cooling the separated soymilk to 85 ~ 90 ℃ 50mL soymilk was dispensed into a beaker. As the tofu coagulant, 3 ~ 5% (v / v) of the raw malic acid extract was added to the beaker and mixed, 2% (v / v) of 20% MgCl 2 solution was added as a positive control group, and distilled water was added as a negative control group. . Tofu was prepared by leaving the sample containing the tofu coagulant at room temperature for 1 hour.

실험예 1: 실험동물 및 실험군의 분류Experimental Example 1: Classification of experimental animals and experimental groups

실험동물은 체중이 100±10g인 Sprague Dawley종의 4주된 웅성 흰쥐를 대한 실험 동물센터에서 구입하여 다시 4주간 건국대학의 동물 사육실에서 적응시켰다. 4주간 적응시키는 동안에 사육실의 온도와 습도는 각각 22 ±2℃, 55 ±5%로 항온 항습을 유지하였다. 식이는 고형사료(삼양사 제품)와 물을 자유롭게 섭취하도록 하였다.The experimental animals were purchased from the experimental animal center of Sprague Dawley species of 100 ± 10g and 4 weeks old male rats, and adapted for 4 weeks in the animal breeding room of Konkuk University. During the four weeks of adaptation, the temperature and humidity of the cage were maintained at 22 ± 2 ° C and 55 ± 5%, respectively. The diet was intended to consume solid feed (Samyang Corporation) and water freely.

4주간 적응시킨 체중이 350g(8주령) 전후의 흰쥐 7마리를 한 군으로 하여 정상대조군(Normal Control), 음성대조군(Negative Control), 양성대조군(Positive Control) 및 실험군(Test group)으로 분류하였다. 음성대조군은 알코올과 물을, 양성대조군은 시판되고 있는 J사의 숙취해소제(숙취해소 및 간기능회복 기능)와 알코올을 섭취하도록 하였다. Seven rats weighing 350 g (8 weeks of age) adapted for 4 weeks were divided into normal control, negative control, positive control, and test groups. . The negative control group consumed alcohol and water, and the positive control group consumed J's hangover relievers (hangover and liver function recovery) and alcohol.

실험군은 알코올과 시판되고 있는 P사의 일반두부를 투여한 T1군(이하 T1으로 표기), 알코올과 생맥산 두부를 투여한 T2군(이하 T2로 표기), 알코올과 생맥산 추출물(맥문동 + 인삼 + 오미자 + 황기 + 호박)을 투여한 T3군(이하 T3로 표기)으로 설정하였다. 이때 식이는 고형 사료(삼양사 제품)를 자유 공급하였고 알코올은 쥐 한 마리 당 5g/kg.bw/day를 섭취하도록 계산하여 매일 음용수에 희석하여 공급하였다. 각 군의 처리는 표 1과 같다.The experimental group included the T1 group (hereinafter referred to as T1) which administered alcohol and commercial tofu of P company (hereinafter referred to as T1), the T2 group (hereinafter referred to as T2) which used alcohol and drafted tofu, and the extract of alcohol and vegetated acid (Macmundong + ginseng + Schisandra + Astragalus + amber) was set to the T3 group (hereinafter referred to as T3) administered. At this time, the diet was freely supplied with solid feed (Samyang Corporation), and alcohol was calculated to consume 5g / kg.bw / day per rat, and was supplied diluted in drinking water daily. The treatment of each group is shown in Table 1.

표 1. Composition of GroupsTable 1. Composition of Groups

Group Group No. of exam No. of exam Treatment Treatment No.1 (Normal Control) No.1 (Normal Control) 77 None-alcoholNone-alcohol No.2 (Negative control) No.2 (Negative control) 77 Alcohol + WaterAlcohol + Water No.3 (Positive Control) No.3 (Positive Control) 77 Alcohol + 숙취해소제Alcohol + Hangover Relief No.4 (Test group1-T1) No.4 (Test group1-T1) 77 Alcohol + 일반두부 Alcohol + regular tofu No.5 (Test group2-T2) No.5 (Test group2-T2) 77 Alcohol + 생맥산두부Alcohol + draft tofu No.6 (Test group3-T3) No.6 (Test group3-T3) 77 Alcohol + 생맥산추출물*Alcohol + Raw Wheat Extract *

*생맥산 추출물: 맥문동(Liriope platyphylla) + 오미자(Schizandra chinensis) + 인삼(Panax ginseng C.A. Meyer) + 황기(Astragalus membranaceus BUNGE) + 호박(Cucurbita spp.)* Salt extract: Limoope platyphylla + Schizandra chinensis + Ginseng (Panax ginseng C.A. Meyer) + Astragalus membranaceus BUNGE + Pumpkin (Cucurbita spp.)

실험예 2: 시료의 제조 및 투여Experimental Example 2: Preparation and Administration of Sample

생맥산 추출물은 맥문동, 오미자, 황기, 인삼 및 호박을 혼합하여 증류수를 첨가하여 가열 추출한 생막산 추출물을 사용하였으며, 일반두부는 시중에서 구입하였고, 생맥산 두부는 10% 두유액에 두유액 양의 3~5%만큼의 생맥산추출물로 실험실에서 직접 두부를 응고시켰다.The raw malt extract was made by mixing Mengmun-dong, Schisandra chinensis, Astragalus, Ginseng and Zucchini and adding extracted distilled water to heat extract. The general tofu was purchased commercially, and the tofu malted tofu was 3 ~ Tofu was coagulated directly in the laboratory with 5% raw malate extract.

일반두부와 생맥산 두부는 60㎏ 성인이 하루 두부 250g을 섭취하는 것을 기준으로 하여 350g 흰쥐에 맞는 양을 계산하였고 생맥산 추출물은 60㎏ 성인이 하루 한약재를 100g 섭취하는 것을 기준으로 하여 역시 350g 흰쥐에 맞는 양을 계산하여 구강 투여하였다.Normal tofu and raw mackerel tofu were calculated for 350g rats based on the intake of 250g of tofu by 60kg adults, and the raw maize extract was also suitable for 350g rats based on the intake of 100g of herbal medicine per day for 60kg adults. The amount was calculated and orally administered.

사육 마지막 날 동물을 overnight로 16시간 절식시키고 에틸에테르로 약하게 마취시킨 상태에서 복부를 절개하고 주사기를 이용하여 후대정맥에서 3∼4㎖ 혈액을 채취한다. EDTA 튜브에 넣어 혈액이 응고하는 것을 방지하였다. 채취한 혈액은 Lactate dehydrogenase(LDH)분석과 혈중 알코올농도 측정, Aspartate aminotransferase(AST), Alanine aminotransferase(ALT), 콜레스테롤, 트리글리세라이드(TG), Malone dialdehyde(MDA)분석에 사용하였다. 채혈 직후 간과 신장을 적출하여, 즉시 냉각된 생리식염수로 세척하고 여과지로 표면의 물기를 제거한 다음 중량을 측정하였다.On the last day of breeding, the animals are fasted overnight for 16 hours, and the abdomen is incised with weakly anesthetized with ethyl ether. Placed in EDTA tube to prevent blood clotting. The collected blood was used for Lactate dehydrogenase (LDH) analysis, blood alcohol concentration measurement, Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), cholesterol, triglyceride (TG) and Malone dialdehyde (MDA) analysis. Liver and kidneys were extracted immediately after blood collection, immediately washed with cooled saline, dried on filter paper, and weighed.

체중은 약물 투여한 날부터 부검하기 전날까지 4주 동안 일주일에 한번씩 같은 시간에 측정하였다. 장기의 중량은 부검 후에 실험동물의 후대정맥을 찾아서 채혈한 후 간, 신장을 각각 적출하고 그 중량을 측정하였다.Body weights were measured at the same time once a week for four weeks from the day of drug administration to the day before necropsy. After the autopsy, the weight of the organ was collected by finding the posterior vena cava of the experimental animal, and then the liver and kidney were extracted and the weight thereof was measured.

실험예 3: 성장과 체중변화량 및 장기중량변화Experimental Example 3: Growth, weight change and organ weight change

Pirola와 Lieber 등[참조: Piola RC and Lieber CS. Energy wastage in rats given drugs that induce microsomalenzymes. J Nutr 105: 1544-1548, 1975]은 쥐에게 알코올을 섭취시켰을 때 체중증가가 저하되었다는 연구 결과를 보고한 바 있고, 이들의 또 다른 연구[참조: Piola RC and Lieber CS. The energy cost of the metabolism of drugs, including ethanol, Phamacology 7: 185, 1972]에 의하면 사람이 전체 에너지 중 50%를 당질 대신 알코올로 섭취하였을 때 체중이 감소되었다는 연구 결과를 제시하였다. 이러한 이유는 알코올 섭취로 인해 산소의 소비가 증가되고 대사율이 증가되며 세포 내 마이크로솜에서 알코올 산화기구의 ATP 생성이 저하되기 때문이다.[참조: Gruchow HW, Sobocinski KA, Barboriak JJ and Scheller JG. Alcoholconsumption, nutrient intake and relative body weight among U.S. adults. Am J Clin Nutr 42: 289-595, 1985] Pirola and Lieber et al., Piola RC and Lieber CS. Energy wastage in rats given drugs that induce microsomalenzymes. J Nutr 105: 1544-1548, 1975 reported that weight gain was reduced when alcohol was ingested in rats. Another study by Piola RC and Lieber CS. The energy cost of the metabolism of drugs, including ethanol, Phamacology 7: 185, 1972, suggests that when people consume 50% of their energy in liquor instead of sugar, they lose weight. This is because alcohol consumption increases oxygen consumption, increases metabolic rate, and decreases ATP production of alcohol oxidative machinery in intracellular microsomes. Gruchow HW, Sobocinski KA, Barboriak JJ and Scheller JG. Alcohol consumption, nutrient intake and relative body weight among U.S. adults. Am J Clin Nutr 42: 289-595, 1985].

본 발명의 결과도 이와 유사한 경향을 나타내었는데 실험동물 Sprague-Dawley(수컷)의 시료 투여 후 4주 동안의 성장과 체중변화량을 측정한 결과 표 2, 도 1 및 도 2에 나타난 바와 같다. 즉, 알코올을 투여한 음성대조군이 다른 군들에 비해 유의적으로 낮은 체중변화량을 나타내었고 일반두부를 투여한 T1군과 생맥산 두부를 투여한 T2군 및 생맥산 추출물을 투여한 T3군은 음성대조군에 비해 체중이 정상대조군에 가까운 유의성 있는 증가를 나타내었고 특히 생맥산 두부를 투여한 T2군에서 현저한 체중증가 효과를 나타내었다. 반면 일반두부를 투여한 T1군은 음성대조군과 비슷한 체중변화량을 보임으로써 알코올 섭취로 인한 체중감소를 거의 회복하지 못하였음을 나타낸다.The results of the present invention also showed a similar trend, as measured in the growth and weight change of 4 weeks after the administration of the sample Sprague-Dawley (male) of the experimental animals as shown in Table 2, Figure 1 and 2. In other words, the alcohol-treated negative control group showed significantly lower body weight change than the other groups, and the T1 group administered normal tofu, the T2 group treated with green maize tofu and the T3 group treated with green maize extract were significantly lower than the negative control group. Body weight showed a significant increase close to the normal control group, especially in the T2 group treated with draft maize tofu. On the other hand, the T1 group who received normal tofu showed a similar weight change as the negative control group, indicating that the weight loss due to alcohol consumption was hardly recovered.

실험예 4: 장기의 중량Experimental Example 4: Weight of Organs

에탄올을 장기적으로 섭취하면 지방간 및 간장의 섬유화로 간이 비대해지게 된다[참조: Han, B. H., M.H. Park, L.K.Woo and Y.N. Han. (1979) Studies on the anti-oxidant components of Korea Ginseng, Korea Biochem. J . , 12 : 33] 간의 중량은 알코올 섭취에 의해 간 조직 내에 지질이 축척됨으로써 알코올을 섭취시킨 모든 군에서 증가 되었다는 연구보고 [참조: Levy, R.I., Bonnel, M. and Ernst, N.D. (1976)J. Am. Dieter. Assoc. , 58 : 406∼417. 및 Lieber,C.S., Don P. Jones. and M. DeCarli. (1965) Am. J. Clin. Nutr ., 44(6) : 1009]와 본 실험 결과도 유사한 경향을 나타내었다. 표 2에 나타난 결과를 보면 알코올을 장기 투여한 음성대조군은 알코올을 투여하지 않은 정상대조군에 비해 대체중간비율(실험동물 체중 100g 당 간중량 %)이 유의적으로 증가하여 지방간 및 간장의 섬유화가 진행되었음 알 수 있었고 따라서 알코올을 장기 투여하면 간이 비대해진다는 위의 보고와 일치함을 알 수 있었다. 그에 반해 생맥산 두부나 생맥산 추출물을 투여한 T2군과 T3군은 대체중간비율이 정상대조군에 가까운 회복세를 나타내어 장기간의 알코올 투여로 인한 지방간 및 간장의 섬유화에 치료 및 개선 효과가 있는 것으로 나타났다. 대체중신장비율(실험동물의 체중 100g 당 신장중량 %)은 모든 실험군이 음성대조군에 유의성(p<0.5)을 보였고 정상대조군에 가까운 수치를 보여 알코올 섭취로 인해 손상된 신장의 회복에 효과가 있음을 나타내었다. 특히 T2군과 T3군이 회복효과를 보였고 양성대조군과 T1군 역시 T2군이나 T3군에는 미치지 못하지만 다소 감소된 수치를 나타내 효과가 있음을 나타내었다.Long-term intake of ethanol causes the liver to become enlarged by fibrosis of fatty liver and liver. Han, B. H., M.H. Park, L.K.Woo and Y.N. Han. (1979) Studies on the anti-oxidant components of Korea Ginseng, Korea Biochem. J. , 12:33] The weight of liver was increased in all groups ingested alcohol by the accumulation of lipids in liver tissue by alcohol intake [Levy, R.I., Bonnel, M. and Ernst, N.D. (1976) J. Am. Dieter. Assoc. 58: 406-417. And Lieber, C. S., Don P. Jones. and M. DeCarli. (1965) Am. J. Clin. Nutr., 44 (6): 1009] and the experimental results showed similar trends. In the results shown in Table 2, the negative control group with long-term administration of alcohol significantly increased the replacement intermediate ratio (% of liver weight per 100g body weight of the test animal) compared to the normal control group without alcohol. Therefore, long-term administration of alcohol is consistent with the above report. On the other hand, T2 and T3 groups treated with raw maize tofu or extract of maeng acid showed a recovery rate near the normal control group, which was effective in treating and improving fibrosis of fatty liver and liver due to prolonged alcohol administration. The rate of replacement neutrophil equipment (% of kidney weight per 100g body weight of the experimental animals) showed that all experimental groups showed a significant (p <0.5) level in the negative control group and were close to the normal control group. Indicated. In particular, the T2 and T3 groups showed a recovery effect, and the positive control group and the T1 group also showed less effective values than the T2 and T3 groups.

표 2. Total body weight gains and the weight ratio of liver and kidneyTable 2.Total body weight gains and the weight ratio of liver and kidney

Group  Group Total body weight gains(g) Mean±S.D.Total body weight gains (g) Mean ± S.D. Liver (% of body weight) Mean±S.D.Liver (% of body weight) Mean ± S.D. Kidney (% of body weight) Mean±S.D.Kidney (% of body weight) Mean ± S.D. No.1 (None-alcohol)No.1 (None-alcohol) 43.67±5.9643.67 ± 5.96 2.646±0.052.646 ± 0.05 0.619±0.020.619 ± 0.02 No.2 (Alcohol)No.2 (Alcohol) 35.17±5.98** 35.17 ± 5.98 ** 2.873±0.07*** 2.873 ± 0.07 *** 0.652±0.03* 0.652 ± 0.03 * No.3(Alcohol+숙취해소제)No.3 (alcohol + hangover remover) 36.00±3.7836.00 ± 3.78 2.705±0.062.705 ± 0.06 0.627±003* 0.627 ± 003 * No.4 (T1)No.4 (T1) 36.00±7.3736.00 ± 7.37 2.716±0.332.716 ± 0.33 0.628±0.04* 0.628 ± 0.04 * No.5 (T2)No.5 (T2) 43.14±10.11* 43.14 ± 10.11 * 2.620±0.12** 2.620 ± 0.12 ** 0.615±0.03* 0.615 ± 0.03 * No.6 (T3)No.6 (T3) 41.57±11.37* 41.57 ± 11.37 * 2.624±0.13** 2.624 ± 0.13 ** 0.619±0.04* 0.619 ± 0.04 *

(Each value represents the mean±S.D. of 7 rats)(Each value represents the mean ± S.D. Of 7 rats)

Means with different superscript asterisks within a column and significantly different from each other at P < 0.5(*) and P < 0.05(**) and P < 0.005(***) as determined by Student's T-test.Means with different superscript asterisks within a column and significantly different from each other at P <0.5 (*) and P <0.05 (**) and P <0.005 (***) as determined by Student's T-test.

실험예 5: 생화학적 검사(LDH, Alcohol농도,AST, ALT, 콜레스테롤, TG, MDA)Experimental Example 5: Biochemical Test (LDH, Alcohol Concentration, AST, ALT, Cholesterol, TG, MDA)

LDH활성치는 LDH키트(Boehringer Mannheim, Germany)를 사용하여 자동 생화학 분석기(Hitachi747, Japan)를 이용하여 측정하였다. 실험 전 흰쥐를 16 ~ 18시간 절식한 후에 1차 투여는 시험물질 + 20%알코올을 각각 2㎖씩 투여하고, 1시간 경과 후 2차 투여시에는 20%알코올을 2㎖씩 투여한 후 1시간 경과 후 3차 투여시에는 20%알코올 + 시험물질을 각각 2㎖씩 투여한 후, 마지막 시험물을 투여한 3시간 후에 혈액을 채취하여 상온에서 30분 정도 방치한 후 원심분리(3000xg·15min)로 혈청을 분리하여 전신피로와 관련이 큰 것으로 알려진 체내에 축적된 젖산치를 자동화학분석기를 이용하여 분석하였다.LDH activity was measured using an automated biochemistry analyzer (Hitachi747, Japan) using an LDH kit (Boehringer Mannheim, Germany). After fasting the rats for 16 to 18 hours before the experiment, the first dose was administered with 2 ml of test substance + 20% alcohol, and after 1 hour, 2 ml of 20% alcohol was administered for 1 hour after 2 hours. After the third dose, 20ml alcohol + 2 ml of test substance was administered, and 3 hours after the last test, blood was collected and allowed to stand at room temperature for 30 minutes, followed by centrifugation (3000xg.15min). Serum was isolated and analyzed for the lactic acid accumulated in the body, which is known to be highly related to systemic fatigue.

Ethanol 농도 측정은 Ethanol 키트(Roche, swizerland)를 사용하여 생화학 분석기(Cobas Integra, Roche, swizerland)를 이용하여 측정하였다. 실험 전 흰쥐를 16 ~ 18시간 절식한 후에 1차 투여는 시험물질 + 20% 알코올을 각각 2㎖씩 투여하고, 1시간 경과 후 2차 투여시는 20%알코올을 2㎖씩 투여한 후 1시간 경과 후 3차 투여시에는 20% 알코올 + 시험물질을 각각 2㎖씩 투여한 후, 마지막 시험물을 투여한 후 90분 후와 180분 후에 혈액을 EDTA tube에 채취하였으며, 대조군 혈액은 알코올 투여를 시작하기 30분 전에 채취하여 각각의 혈중 알코올 농도를 생화학 분석기로 측정하였다.Ethanol concentration was measured using a ethanol kit (Roche, swizerland) using a biochemical analyzer (Cobas Integra, Roche, swizerland). After fasting the rats for 16 to 18 hours before the experiment, the first dose was administered with 2 ml of test substance + 20% alcohol, and after 1 hour, 2 ml of 20% alcohol was administered for 2 hours. After the third dose, 20 ml alcohol + 2 ml of test substance was administered, and after 90 minutes and 180 minutes after the last test, blood was collected into the EDTA tube. Thirty minutes before starting, each blood alcohol level was measured by a biochemical analyzer.

채혈한 혈액을 30분 동안 실온에 방치한 후 3000 ×g에서 15분간 원심분리 하여 얻은 혈장의 AST활성치는 AST 키트(Boehringer Mannheim, Germany)를 사용하여 측정하였다. 혈장중의 AST의 작용으로 aspartic acid와 α-ketoglutamic acid는 oxaloacetic acid와 L-glutamic acid로 변화한다. 이때 생성된 oxaloacetic acid는 조효소 NADH의 존재 하에 MDH의 작용으로 malate로 변화되고 이때 NADH가 NAD + 로 산화될 때의 흡광도 감소치를 파장 340 nm에서 자동 생화학 분석기(Hitachi 747)로 측정하였다.Plasma collected blood was left at room temperature for 30 minutes and centrifuged at 3000 xg for 15 minutes. The AST activity of plasma was measured using an AST kit (Boehringer Mannheim, Germany). Aspartic acid and α-ketoglutamic acid are converted to oxaloacetic acid and L-glutamic acid by the action of AST in plasma. The produced oxaloacetic acid was converted to malate by the action of MDH in the presence of coenzyme NADH, and the decrease in absorbance when NADH was oxidized to NAD + was measured by an automatic biochemical analyzer (Hitachi 747) at wavelength 340 nm.

ALT의 활성치는 ALT(Boehringer Mannheim, Germany) 키트를 사용하여 자동 생화학 분석기(Hitachi 747)로 측정하였다. 혈장중의 ALT 작용으로 L-alanine과 α-ketoglutamine acid는 pyruvic acid와 L-glutamic acid로 변화한다. 생성된 pyruvate는 조효소 NADH의 존재 하에 LDH의 작용으로 lactate로 변화되고 이때 NADH가 NAD + 로 산화될 때의 흡광도 감소치를 파장 340nm에서 자동 생화학 분석기(Hitachi 747)로 측정하였다.Activity of ALT was measured by an automated biochemistry analyzer (Hitachi 747) using ALT (Boehringer Mannheim, Germany) kit. L-alanine and α-ketoglutamine acid are converted to pyruvic acid and L-glutamic acid by ALT action in plasma. The pyruvate produced was converted to lactate by the action of LDH in the presence of coenzyme NADH, and the absorbance decrease when NADH was oxidized to NAD + was measured by an automatic biochemical analyzer (Hitachi 747) at wavelength 340nm.

트리글리세라이드(TG)는 글리세롤 비소거법에 의해 TG 키트 (Boehringer Mannheim, Germany)를 이용하여 자동분석기(Hitachi 747)에서 측정하였고, 콜레스테롤은 enzymatic coloimetric test를 이용하여 T. chol. 키트 (Boehringer Mannheim, Germany)를 사용하여 자동 분석기(Hitachi 747)로 측정하였다.Triglyceride (TG) was measured by an autoanalyzer (Hitachi 747) using a TG kit (Boehringer Mannheim, Germany) by the glycerol non-erasing method, and cholesterol was measured using T. chol. Measurements were made with an automated analyzer (Hitachi 747) using a kit (Boehringer Mannheim, Germany).

MDA치는 MDA키트(Bioxtech LPO-586 Assay, Oxis International, Inc. America)를 이용하여 Spectrophotometer(HP8425A. Hewlette Packard.America)로 분석하였다. 체내에 생성된 활성산소가 체내지방과 결합하여 과산화 지질을 생성하며, 체내의 과산화 지질은 각종 성인병과 관련되어 인간노화의 원인물질로 작용하므로 생맥산 두부의 항 산화작용을 확인하기 위하여 과산화지질을 비색계로 측정하였다.MDA values were analyzed with a Spectrophotometer (HP8425A. Hewlette Packard.America) using an MDA kit (Bioxtech LPO-586 Assay, Oxis International, Inc. America). The active oxygen produced in the body combines with the fat in the body to produce lipid peroxide, and the lipid peroxide in the body acts as a causative agent of human aging in connection with various adult diseases. Was measured.

모든 실험 결과 측정치는 일변수 분석법을 사용하여 통계처리 하였으며 Student's T-test를 이용하여 p<0.5 수준에서 각 실험군 간의 유의성을 검증하였다. 모든 자료는 mean ±standard deviation으로 나타내었다.All experimental results were statistically analyzed using one-variable analysis method, and Student's T-test was used to verify the significance of each experimental group at p <0.5 level. All data are expressed as mean ± standard deviation.

실험예 6: 생맥산 추출물의 항 피로 효과Experimental Example 6: Anti-Fatigue Effect of Draft Macaric Acid Extract

표 3과 도 3에 본 발명에 의해 추출되는 생맥산 추출물의 항 피로 효과를 나타내었다. 간기능 장해물질을 투여하여 체내에 젖산이 축척되는 수치 변화를 유도하여 생맥산 추출물 투여군과 비교하여 항 피로 효과를 평가하는데 치료물질을 섭식시킨 경우는 간기능 장애물질 섭식군과 유사하게 높은 젖산수치로 나타났으나 생맥산추출물을 섭식시킨 동물의 젖산 수치는 거의 정상상태로 억제된 것으로 보아 생맥산 추출물이 항 피로작용을 나타낸 것을 알 수 있다.Table 3 and Figure 3 shows the anti-fatigue effect of the raw malt extract extracted by the present invention. To evaluate the anti-fatigue effect by inducing the change in the level of lactic acid accumulated in the body by administering the liver function disorder substance, the treatment substance was fed to the high lactate level similar to the liver function obstacle feeding group. However, the lactic acid level of the animals fed the malt extract was suppressed to a nearly normal state, indicating that the anti-fatigue extract showed anti-fatigue activity.

표 3. 항 피로 효과Table 3. Anti-Fatigue Effects

Group Group 젖산농도 (U/L)Lactate Concentration (U / L) Mean±S.D.Mean ± S.D. Range(min-max)Range (min-max) 시료1Sample 1 사료 feed 1,059.75±409.671,059.75 ± 409.67 432-1,562432-1,562 시료2Sample 2 사료+간기능장해물질Feed + liver disorders 1,348.20±465.551,348.20 ± 465.55 845-1,959845-1,959 시료3Sample 3 사료+간기능장해물질+ 간기능치료물질(숙취해소제)Feed + liver function disorder + liver function therapeutic substance (hang hanger) 1,364.33±176.931,364.33 ± 176.93 1,098-1,4971,098-1,497 시료4Sample 4 사료+간기능장해물질+생맥산추출물Feed + Liver Function Disorder + Raw Wheat Extract 1,194.00±251.331,194.00 ± 251.33 847-1,496847-1,496

(Each value represents the mean ± S.D. of 7rats)(Each value represents the mean ± S.D. of 7rats)

실험예 7: 생맥산 추출물의 알코올 분해 효과Experimental Example 7: Alcohol Degradation Effect of Draft Macaric Acid Extract

표 4와 도 4에 본 발명에 의해 추출되는 생맥산 추출물의 알코올 분해효과를 나타내었다. 알코올을 투여한 후 1시간 30분 후의 측정치는 시료 3이 가장 낮은 값으로 나타났지만, 3시간 후에 혈중 알코올 농도를 측정한 결과는 생맥산추출물을 투여한 군이 다른 군보다 알코올 농도가 현저하게 감소한 것으로 나타남으로써, 생맥산 추출물의 알코올 분해작용은 물론 숙취해소와 지방간을 예방할 수 있음을 알 수 있다.Table 4 and Figure 4 shows the alcohol degradation effect of the raw machsan extract extracted by the present invention. 1 hour and 30 minutes after alcohol administration, Sample 3 showed the lowest value, but after 3 hours, blood alcohol concentration was significantly lower than that of other groups. By appearing, it can be seen that the alcohol-degrading action of the raw malt extract can prevent hangover and prevent fatty liver.

표 4. 알코올 분해 효과Table 4. Alcohol Degradation Effects

Group Group 알코올 농도 (%)Alcohol concentration (%) 1시간 30분1 hour 30 minutes 3시간3 hours 사료 섭식Feed 00 00 장해물질 섭식Hazardous Substance Feeding 0.170.17 0.160.16 숙취해소제 섭식Hangover Eating 0.150.15 0.140.14 생맥산 추출물 섭식Feeding draft malic acid extract 0.170.17 0.110.11

(Each value represents the mean ± S.D. of 7rats)(Each value represents the mean ± S.D. of 7rats)

실험예 8: 혈장 트리글리세라이드 함량Experimental Example 8: Plasma Triglyceride Content

표 5와 도 5에 혈장 트리글리세라이드 함량을 나타내었다. 알코올만을 장기 투여한 음성대조군은 73.71 ±61.20 mg/dL로 정상대조군의 39.57 ±8.62 mg/dL에 비해 혈장 내 트리글리세라이드 함량이 현저히 증가하여 장기간의 알코올 투여로 인해 고지혈증이 유도된 것을 알 수 있었다. 보고된 바에 의하면 장기간의 알코올 섭취는 트리글리세라이드 함량을 현저하게 높여주어 지방간을 유도하며, 특히 만성적 알코올 섭취는 지방간을 초래하여 영양불량의 주요원인이 되는데[참조: Rahimtoola SH. (1985) 콜레스테롤 and coronary heart disease.J. Am. Med. Assoc. 253 : 2094∼2095 및Castelli WP, Wilson PW, Levy D, Anderson K. (1990) Serum Lipids and risk of coronary artery disease. Athe roscl. Rev . 21 : 7∼10.] 이로 인한 음식물의 섭취감소 특히 단백질, methionine, choline, vitamin E, Se 등의 항지방간 인자들의 결핍을 초래한다[참조: Cutta, S.K., P.A. Miller, L.B. Greenberg and O.A. Levander (1983) Celenium and acute alcoholism. Am. J. Clin. Nutr. 38 : 713∼718]. Table 5 and Figure 5 shows the plasma triglyceride content. In the long-term negative alcohol control group, 73.71 ± 61.20 mg / dL showed a significant increase in plasma triglyceride content compared to 39.57 ± 8.62 mg / dL of the normal control group, indicating that hyperlipidemia was induced by long-term alcohol administration. It has been reported that long-term alcohol intake significantly increases triglyceride content, leading to fatty liver, and in particular chronic alcohol intake can lead to fatty liver, leading to malnutrition [Rahimtoola SH. (1985) Cholesterol and coronary heart disease. Am. Med. Assoc. 253: 2094-2095 and Castelli WP, Wilson PW, Levy D, Anderson K. (1990) Serum Lipids and risk of coronary artery disease. Athe roscl. Rev. 21: 7-10.] This leads to a decrease in food intake, especially the deficiency of anti-fatty factors such as protein, methionine, choline, vitamin E and Se [Cutta, S.K., P.A. Miller, L.B. Greenberg and O.A. Levander (1983) Celenium and acute alcoholism. Am. J. Clin. Nutr. 38: 713-718].

본 발명에서 결과 T1군은 30.20 ±4.71 mg/dL, T2군은 26.57 ±1.68 mg/dL, T3군은 27.29 ±6.96 mg/dL의 혈장내 트리글리세리드 함량을 나타내어 음성대조군과 비교할 때 T2군과 T3군이 현저히 고지혈증을 개선시키는 유의성 있는(p<0.05, p<0.01) 연구 결과를 나타내었으며 이는 생맥산 추출물(맥문동, 오미자, 인산, 황기, 호박)이나 또는 생맥산 두부가 매우 효과적으로 고지혈증을 치료 또는 개선할 수 있음을 의미하는 결과를 나타내었다.In the present invention, the T1 group showed a plasma triglyceride content of 30.20 ± 4.71 mg / dL, the T2 group 26.57 ± 1.68 mg / dL, and the T3 group 27.29 ± 6.96 mg / dL, compared with the negative control group T2 and T3 group These studies have shown significant (p <0.05, p <0.01) studies that significantly improve hyperlipidemia, which can be used to treat or improve hyperlipidemia very effectively with either raw malic acid extract (Mangmun-dong, Schizandra chinensis, Phosphoric acid, Astragalus, or Pumpkin) or fresh maize tofu. The results indicate that there is.

실험예 9: 혈장의 총 콜레스테롤 함량Experimental Example 9: Total Cholesterol Content in Plasma

표 5와 도 6에 혈장 내 콜레스테롤 함량을 나타내었다. 정상군의 95.71 ±6.86 mg/dL에 비해 음성대조군의 혈장 내 콜레스테롤 함량은 113.80 ±38.19 mg/dL로 증가하여 혈장 내 트리글리세리드 함량의 경우와 마찬가지로 장기간의 알코올 투여로 인해 고지혈증이 유발되었음을 알 수 있었다. 실험군 중 T1군은 86.17 ±5.58 mg/dL, T2군은 85.00 ±5.76 mg/dL 및 T3군은 84.00 ±9.20 mg/dL의 수치를 나타내어 모든 실험군에서 현저히 콜레스테롤 수치를 감소시키는 유의성 있는(p<0.05) 결과를 나타내어 뛰어난 고지혈증 개선 및 치료 효과를 기대할 수 있는 가능성을 나타내었다.Table 5 and Figure 6 shows the cholesterol content in the plasma. The plasma cholesterol content of the negative control group was increased to 113.80 ± 38.19 mg / dL compared to 95.71 ± 6.86 mg / dL of the normal group, indicating that hyperlipidemia was induced by long-term alcohol administration as in the case of the plasma triglyceride content. The T1 group had 86.17 ± 5.58 mg / dL, the T2 group had 85.00 ± 5.76 mg / dL, and the T3 group had 84.00 ± 9.20 mg / dL, significantly reducing cholesterol levels in all experimental groups (p <0.05). ), The results showed the possibility to expect excellent hyperlipidemia improvement and treatment effect.

혈액 중 높은 콜레스테롤 농도가 고혈압과 동맥경화증 등 심혈관계 질환 유발의 주요인자로 작용한다는 보고[참조: Rahimtoola SH. (1985) 콜레스테롤 and coronary heart disease.J. Am. Med. Assoc. 253 : 2094∼2095; Castelli WP, Wilson PW, Levy D, Anderson K. (1990) Serum Lipids and risk of coronary artery disease. Atheroscl. Rev . 21 : 7∼10; 및 Miettinen TA. (1987) Dietary fiber and lipids.Am. J. Clin. Nutr . 45 : 1237∼1242]에 비추어 각개인의 혈장 콜레스테롤 농도를 낮추는 약품과 기능성물질 개발에 세계적으로 많은 연구와 노력이 진행되고 있으며 특히 인체에 부작용이 적은 천연물로부터 위의 약재, 또는 기능성물질을 개발하였을 경우 그 부가가치는 막대하리라고 예상된다. 이러한 관점에서 볼 때, 본 연구의 결과들은 신규 천연 고지혈증 치료제로서의 가능성을 제시해 준다.High cholesterol levels in blood have been shown to be a major factor in the induction of cardiovascular diseases such as hypertension and atherosclerosis. Rahimtoola SH. (1985) Cholesterol and coronary heart disease. Am. Med. Assoc. 253: 2094-2095; Castelli WP, Wilson PW, Levy D, Anderson K. (1990) Serum Lipids and risk of coronary artery disease. Atheroscl. Rev. 21: 7-10; And Miettinen TA. (1987) Dietary fiber and lipids. Am. J. Clin. Nutr. 45: 1237 ~ 1242], many studies and efforts are being conducted worldwide to develop drugs and functional substances that lower the plasma cholesterol level of each individual. Especially, the above medicines or functional substances have been developed from natural products which have little side effects on the human body. The value added is expected to be enormous. In this regard, the results of this study offer potential as a novel natural hyperlipidemia treatment.

표 5. Concentration of plasmid lipid in the rat.Table 5. Concentration of plasmid lipid in the rat.

Group Group TG(mg/dL) Mean±S.D.TG (mg / dL) Mean ± S.D. CHOL(mg/dL) Mean±S.D.CHOL (mg / dL) Mean ± S.D. No.1 (None-alcohol)No.1 (None-alcohol) 39.57±8.62** 39.57 ± 8.62 ** 92.80±6.01* 92.80 ± 6.01 * No.2 (Alcohol)No.2 (Alcohol) 73.71±61.2073.71 ± 61.20 113.80±38.19113.80 ± 38.19 No.3(Alcohol+숙취해소제)No.3 (alcohol + hangover remover) 30.14±6.7330.14 ± 6.73 91.57±6.3091.57 ± 6.30 No.4 (T1)No.4 (T1) 30.20±4.7130.20 ± 4.71 86.17±5.58* 86.17 ± 5.58 * No.5 (T2)No.5 (T2) 26.57±1.68**** 26.57 ± 1.68 **** 85.00±5.76** 85.00 ± 5.76 ** No.6 (T3)No.6 (T3) 27.29±6.96*** 27.29 ± 6.96 *** 84.00±9.20** 84.00 ± 9.20 **

(Each value represents the mean±S.D. of 7 rats)(Each value represents the mean ± S.D. Of 7 rats)

Means with different superscript asterisks within a column and significantly different from each other at P < 0.5(*) and P < 0.1(**) and P < 0.05(***) and P < 0.01(****) as determined by Student's T-test.Means with different superscript asterisks within a column and significantly different from each other at P <0.5 (*) and P <0.1 (**) and P <0.05 (***) and P <0.01 (****) as determined by Student's T-test.

실험예 10: 혈장 AST, ALT 효소활성도 변화Experimental Example 10: Changes in Plasma AST and ALT Enzyme Activities

표 6과 도 7, 도 8은 일반두부 투여군(T1)과 생맥산 두부 투여군(T2), 그리고 생맥산 추출물 투여군(T3)의 간 기능활성효과를 알아보기 위해 4주 간 시료 투 여 후 혈장 AST, ALT 수치의 변화를 나타낸 것으로 AST는 L-Aspartate + α-ketoglutarate 에 반응하여 oxaloacetate + glutamate를 생성시키며 oxaloacetate를 pyruvate로 변화시키는 과정에 참여하는 효소이며, ALT 는 DL-Alanine + α-krtoglutarate 에 반응하여 pyruvate + glutamate를 생성시키는 전이 효소로 이 효소들은 그 활성 치가 증가하면 간 기능이 저하되었음을 알려주므로 간 질환 판정효소로 알려져 있다.Tables 6, 7 and 8 show plasma AST and ALT after administration of the sample for 4 weeks to examine the hepatic functional activity of the general tofu administration group (T1), the draft tofu administration group (T2), and the draft corn extract extract group (T3). AST is an enzyme involved in the process of producing oxaloacetate + glutamate in response to L-Aspartate + α-ketoglutarate and converting oxaloacetate to pyruvate, and ALT in response to DL-Alanine + α-krtoglutarate It is a transfer enzyme that produces glutamate. These enzymes are known as liver disease determinants because they indicate that liver function is decreased when their activity is increased.

표 6 및 도 7에 나타난 바와 같이 normal control의 혈장 중 AST 치는 84.43 ±47.88 U/L였으나 알코올을 장기간 투여한 음성대조군의 AST 수치는 254.57 ±463.20 U/L로 약 3배 가량의 상승을 보여 장기간의 알코올 투여로 인해 간손상이 유도되었음을 알 수 있었다. 이에 반해 T2군과 T3군은 61.00 ±3.78 U/L, 64.80 ±6.24 U/L의 AST 활성치를 나타내 음성대조군은 물론 양성대조군(positive control)의 70.29 ±12.60 U/L과 비교했을 때 매우 뛰어난 AST 상승 억제효과를 나타낸 것을 알 수 있었으며 알코올과 함께 일반두부를 투여한 T1군은 78.40 ±36.77 U/L로 AST 상승 억제 효과를 나타내긴 했지만 유의성(p<0.5)을 보이지는 않았다.As shown in Table 6 and FIG. 7, the AST level in the plasma of the normal control was 84.43 ± 47.88 U / L, but the AST level of the negative control group administered with alcohol for an extended period of time was 254.57 ± 463.20 U / L. Hepatic damage was induced by alcohol administration. In contrast, the T2 and T3 groups exhibited AST activities of 61.00 ± 3.78 U / L and 64.80 ± 6.24 U / L, which is very good when compared to the negative control and 70.29 ± 12.60 U / L of the positive control. Synergistic inhibitory effect was found. T1 group who received regular tofu with alcohol showed AST synergistic inhibitory effect with 78.40 ± 36.77 U / L, but did not show any significant (p <0.5).

표 6 및 도 8에 ALT 효소 활성치를 나타내었다. 정상군의 ALT 수치는 44.00 ±9.04 U/L로 나타났으며 이에 비해 음성대조군은 215.43 ±428.93 U/L으로 정상군에 비해 매우 높은 수치를 나타내어 장기간의 알코올 투여로 인한 간손상을 확인할 수 있었다. T2군과 T3군은 각각 34.14 ±5.49 U/L 및 36.40 ±8.50 U/L으로 정상군보다도 유의적으로(p<0.5) 낮은 수치를 나타냈으며 알코올과 함께 일반두부를 투여한 T1군 역시 T2군이나 T3군에는 미치지 못하지만 37.83 ±6.57 U/L로 낮은 활성치 를 보였다.Table 6 and Figure 8 shows the ALT enzyme activity. The ALT level of the normal group was 44.00 ± 9.04 U / L, whereas the negative control group was 215.43 ± 428.93 U / L, which was very high compared to the normal group, indicating that hepatic damage due to prolonged alcohol administration was confirmed. T2 and T3 groups were 34.14 ± 5.49 U / L and 36.40 ± 8.50 U / L, respectively (p <0.5), which were significantly lower than those of normal group. It did not reach the T3 group, but showed low activity with 37.83 ± 6.57 U / L.

일반적으로 알코올의 장기 섭취는 AST 및 ALT의 활성치를 증가시키는 경향이 있으며 이는 곧 간 기능의 활성이 감소됨을 시사해주는 것이다. 간기능이 저하될 때 간에서 제일 먼저 나타나는 임상증상의 하나가 AST, ALT 활성의 증가로 볼 수 있다[참조: Kien, C.L. and H.E. Ganther (1983) Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am. J. Clin. Nutr. 37 : 319∼328. 및 Thompson, J.N. and M.L Scott (1970) Impaired lipid and Vitamin E absorption related to atrophy of the pancreas in selenium-deficient chicks. J. Nutr . 100 : 797∼809]. 특히 혈장 ALT는 간세포 변성과 괴사를 예민하게 반영하여 상승하기 때문에 특히 간 담도 질환의 유력한 지표로서 널리 이용되고 있다[참조: 김순호, 손한철, 이은엽, 장철훈 (1999) 최신 임상검사진단학, 계측문화사, pp. 50∼52].In general, long-term intake of alcohol tends to increase the activity of AST and ALT, suggesting decreased activity of liver function. One of the first clinical manifestations in the liver when hepatic function is impaired is an increase in AST and ALT activity [Kien, C.L. and H.E. Ganther (1983) Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am. J. Clin. Nutr. 37: 319-328. And Thompson, J.N. and M.L Scott (1970) Impaired lipid and Vitamin E absorption related to atrophy of the pancreas in selenium-deficient chicks. J. Nutr. 100: 797 to 809]. In particular, plasma ALT is widely used as a potent indicator of hepatobiliary tract disease because it is sensitive to hepatocellular degeneration and necrosis [Soon-Ho Kim, Han-Cheol Son, Eun-Yeop Lee, and Chul-Hoon Jang (1999). . 50 to 52].

본 발명에서 나타난 결과를 살펴보면 장기간의 알코올 섭취로 발생된 간기능 장애에 맥문동, 오미자, 인삼, 황기, 호박 등의 한약재를 복합처방한 생맥산 추출물 뿐만 아니라 이 생맥산 두부가 상당한 회복효과를 나타내는 것을 알 수 있으며, 장기 투여하였을 때 간기능 장애의 회복기능이 생맥산 추출물을 단독으로 투여했을 때 보다 현저히 증가함을 알 수 있었다.Looking at the results shown in the present invention it can be seen that not only the Sangmasan extract, which is a combination of herbal medicine such as McMun-dong, Schisandra chinensis, Ginseng, Astragalus, pumpkin, etc. in the liver dysfunction caused by long-term alcohol intake, but also the saengmaek tofu has a significant recovery effect In addition, it was found that the long term administration significantly improved the recovery function of liver dysfunction than when the raw malic acid extract was administered alone.

표 6. Enzyme activity of AST and ALT in plasmaTable 6. Enzyme activity of AST and ALT in plasma

Group Group AST(U/L) Mean±S.D.AST (U / L) Mean ± S.D. ALT(U/L) Mean±S.D.ALT (U / L) Mean ± S.D. No.1 (None-alcohol)No.1 (None-alcohol) 84.43±47.88* 84.43 ± 47.88 * 44.00±9.04* 44.00 ± 9.04 * No.2 (Alcohol)No.2 (Alcohol) 254.57±463.20254.57 ± 463.20 215.43±428.93215.43 ± 428.93 No.3(Alcohol+숙취해소제)No.3 (alcohol + hangover remover) 70.29±12.60* 70.29 ± 12.60 * 37.29±9.30* 37.29 ± 9.30 * No.4 (T1)No.4 (T1) 78.40±36.7778.40 ± 36.77 39.20±9.22* 39.20 ± 9.22 * No.5 (T2)No.5 (T2) 61.00±3.78* 61.00 ± 3.78 * 34.14±5.49** 34.14 ± 5.49 ** No.6 (T3)No.6 (T3) 64.80±6.24* 64.80 ± 6.24 * 36.40±8.50* 36.40 ± 8.50 *

(Each value represents the mean±S.D. of 7 rats)(Each value represents the mean ± S.D. Of 7 rats)

Means with different superscript asterisks within a column and significantly different from each other at P < 0.5(*) and P < 0.05(**) as determined by Student's T-test.Means with different superscript asterisks within a column and significantly different from each other at P <0.5 (*) and P <0.05 (**) as determined by Student's T-test.

실험예 11: 혈장의 MDA함량 Experimental Example 11: MDA content of plasma

표 7과 도 9에 malone dialdehyde(MDA)함량을 나타내었다. 알코올만 투여한 음성대조군은 5.7±3.24 마이크로μ㏖로 정상대조군의 4.40±0.13에 비해 혈장내 MDA함량이 현저히 증가하여 장기간의 알코올 투여로 인해 과산화지질 생성이 유도된 것을 알 수 있었다. 보고된 바에 의하면 체내의 활성산소가 체내지방과 결합하여 과산화지질을 생성하며 체내에 형성된 과산화지질은 각종 성인병과 관련되어 노화를 촉진하는 노화의 원인물질로 알려져 있다.Table 7 and Figure 9 shows the malone dialdehyde (MDA) content. The alcohol-only negative control group was 5.7 ± 3.24 microμmol, which significantly increased plasma MDA content compared to the normal control group's 4.40 ± 0.13, indicating that lipid peroxide production was induced by long-term alcohol administration. Reportedly, active oxygen in the body binds with body fat to produce lipid peroxide, and the lipid peroxide formed in the body is known as a cause of aging that promotes aging associated with various adult diseases.

본 실험결과 일반 두부를 투여한 T1군은 5.97±1.91μ㏖로 음성대조군과 유사한 높은 수치를 보이는 반면 생맥산 두부를 투여한 T2군은 4.82±0.45μ㏖로 유의성 있는 (P < 0.1)낮은 수치를 보여 생맥산 두부가 항 산화 및 항 노화효과를 나타낸 것으로 판단되었다.The T1 group who received normal tofu showed a high value similar to the negative control group with 5.97 ± 1.91μmol, whereas the T2 group who received the DST was 4.82 ± 0.45μmol (P <0.1). Drafted tofu was shown to have antioxidant and anti-aging effects.

표 7. Concentration of malondialdehyde in rat.Table 7. Concentration of malondialdehyde in rat.

Group Group MDA(umol) Mean±S.D.MDA (umol) Mean ± S.D. No.1 (None-alcohol)No.1 (None-alcohol) 4.40±0.134.40 ± 0.13 No.2 (Alcohol)No.2 (Alcohol) 5.70±3.24* 5.70 ± 3.24 * No.3(Alcohol+숙취해소제)No.3 (alcohol + hangover remover) 4.56±60.15** 4.56 ± 60.15 ** No.4 (T1:Alcohol+일반두부)No.4 (T1: Alcohol + regular tofu) 5.97±1.91** 5.97 ± 1.91 ** No.5 (T2:Alcohol+생맥산두부)No.5 (T2: Alcohol + draft tofu) 4.82±0.45** 4.82 ± 0.45 **

(Each value represents the mean±S.D. of 7 rats)(Each value represents the mean ± S.D. Of 7 rats)

Means with different superscript asterisks within a column and significantly different from each other at P < 0.5(*) and P < 0.1(**) as determined by Student's T-test.Means with different superscript asterisks within a column and significantly different from each other at P <0.5 (*) and P <0.1 (**) as determined by Student's T-test.

실험예 12: 생맥산 추출물이 생체에 미치는 아급성 독성실험Experimental Example 12: Subacute Toxicity Test of Raw Macaric Acid Extracts

생맥산 추출물이 생체에 미치는 아급성 독성을 실험하기 위하여 실험동물은 체중이 250 ±10g인 Sprague-Dawley(SD)계의 7주된 웅성 흰쥐를 대한 실험 동물센터에서 구입하여 10일간 건국 대학의 동물사육실에서 적응시켰다. 적응시키는 동안에 사육실의 온도와 습도는 각각 22 ±2℃, 55 ±5%로 항온, 항습을 유지하였고 식이는 고형사료(삼양사)와 물을 자유롭게 섭취하도록 하였다.In order to test the subacute toxicity of bio-macroic acid extracts in vivo, experimental animals purchased Sprague-Dawley (SD) male 7-week-old male rats weighing 250 ± 10 g from the experimental animal center for 10 days in the animal nursery of Konkuk University. Adapted. During adaptation, the temperature and humidity of the feeding room were 22 ± 2 ℃ and 55 ± 5%, respectively, maintaining constant temperature and humidity. The diet was allowed to consume solid feed (Samyangsa) and water freely.

10일 간 사육실에 적응시킨 체중이 300 g 전후의 흰쥐 6마리를 한 군으로 하여 정상대조군(Normal control group) 및 실험군(Test group)으로 분류하였다. 정상대조군은 사료와 물을 자유 섭식토록 하였으며 매일 오전 11시 30분 2㎖의 증류수를 경구 투여하였다. 실험군 1(이하 T1로 표기)은 사료와 물을 자유 섭식토록 하 였으며 매일 오전 11시 30분 생맥산 추출물 2㎖을 경구 투여하였다. 이때 식이는 삼양사의 고형사료를 자유 공급하였으며 각 군의 처리는 표 8과 같다.Six rats of about 300 g body weight adjusted to the rearing room for 10 days were divided into a normal control group and a test group. The normal control group was allowed to freely feed and water and orally administered 2ml of distilled water at 11:30 am daily. Experimental group 1 (hereinafter referred to as T1) allowed free feeding of food and water, and orally administered 2 ml of raw malic acid extract at 11:30 am daily. At this time, the diet freely supplied Samyang's solid feed, and the treatment of each group is shown in Table 8.

표 8. Composition of GroupsTable 8. Composition of Groups

Group Group No. of exam No. of exam Treatment Treatment No.1 (Normal Control)No.1 (Normal Control) 66 사료 + 음용수 + 증류수Feed + drinking water + distilled water No.2 (Test group1-T1)No.2 (Test group1-T1) 66 사료 + 음용수 + 생맥산추출물1 ) Feed + drinking water + raw extract 1 )

*생맥산추출물1 ): 맥문동(Liriope platyphylla) + 오미자(Schizandra chinensis) + 인삼(Panax ginseng C.A. Meyer) + 황기(Astragalus membranaceus BUNGE) + 호박(Cucurbita spp.)추출물* Make Extracts 1 ) : Limoope platyphylla + Schizandra chinensis + Ginseng (Panax ginseng CA Meyer) + Astragalus membranaceus BUNGE + Pumpkin (Cucurbita spp.) Extract

한약시료는 경동약재시장에서 구입한 인삼(Panax ginseng C. A. Meyer, 충청남도 금산산), 황기(Astragalus membranaceus BUNGE, 강원도 양양산), 오미자(Schizandra chinensis), 맥문동 (Liriope platyphylla) 및 호박 (Cucurbita spp.)을 혼합하여 총 100g의 한약재에 3차 증류수 1,000㎖을 첨가하여 2시간 30분 동안 끓인 후(대웅약탕기, DWP-2000M) 거즈로 1차 여과하고, 3MM Paper로 2차 여과한 후 최종 volume을 400㎖로 하여 4℃ 냉장고에 보관하면서 사용하였다. 생맥산추출물 400㎖를 사람에게 1일 투여하는 양으로 계산하여 300g의 랫트에게 28일 동안 매일 2㎖ 씩 경구투여 하였다.Herbal medicine samples from Pandong ginseng CA Meyer (Gumsan, Chungcheongnam-do), Astragalus membranaceus BUNGE (Yangyang, Gangwon-do), Schizandra chinensis, Liriope platyphylla and Cucurbita spp. Mixed with 100 g of herbal medicine, add 1,000 ml of tertiary distilled water, boil for 2 hours and 30 minutes (Daewoong tangtang machine, DWP-2000M), filter it first with gauze, filter it with 3MM paper and filter the final volume 400 The solution was used while storing it in a 4 ° C. refrigerator. 400 ml of raw malic acid extract was calculated as the amount administered daily to humans, and 300 g rats were orally administered to 2 ml daily for 28 days.

시료 투여 시 일반상태 이상유무 관찰하기 위하여 매일 적어도 2회 이상 동물의 일반상태를 세밀히 관찰하였다. 일반상태로서 피부, 피모, 안·점막, 배변, 운동 및 패턴 등에 대하여 이상상태의 발현시간, 정도, 지속시간을 관찰하였고 또 서로에 대한 공격성의 증가 유무, 자해 유무, 조직의 자기융해 등을 면밀히 관찰 체크하였다. 그리고 군마다의 동물수를 항상 확인하여 시험동물의 실종을 체크하였다.In order to observe the general condition abnormality when administering the sample, the general condition of the animal was closely observed at least two times daily. As a general condition, the expression time, degree, and duration of abnormal condition were observed for skin, hair, eye, mucous membrane, bowel movement, movement, and pattern, and closely examined whether there is an increase in aggression against each other, self-harm, and tissue fusion. Observation checked. And the number of animals in each group was always checked to check the disappearance of test animals.

부검 후 각 장기의 이상유무 관찰하기 위하여 부검 후에는 복강 내 각 기관들의 색깔, 크기, 외형적 변화 등을 육안으로 관찰하여 이상 유무를 체크하고 간장과 신장은 보존액에 보존하였다.In order to observe the abnormality of each organ after necropsy, the color, size, and appearance of each organ in abdominal cavity were visually observed to check for abnormalities, and the liver and kidneys were preserved in the preservative solution.

사망률 측정을 위하여 시료 투여 28일간 각 군의 랫트 사망률을 측정하였다. 또한 체중 측정(1회/1주일) 및 기관중량측정(부검 후)을 위하여 체중은 시료 투여 후 부검하기 전날까지 4주 동안 일주일에 한번씩 같은 시간에 측정하였으며 장기의 중량은 부검 후에 실험동물의 후대정맥을 찾아서 채혈한 후 각 군의 실험동물의 간 및 신장을 정확히 적출하고 각각의 중량을 측정하여 대체중 장기비율을 계산하였다. 섭이량 및 섭수량 측정을 위하여 시료 투여 28일간 1회/1일, 매일 동일시간에 각 군의 섭이량 및 섭수량을 측정하여 이상유무를 관찰하였다.To determine mortality, rat mortality was measured in each group for 28 days. In addition, for weight measurement (once a week) and organ weight measurement (after necropsy), the body weight was measured at the same time once a week for 4 weeks until the day before necropsy after administration of the sample. After finding and sampling the vena cava, the liver and kidney of each group of animals were accurately extracted and the weight of each group was measured to calculate the long-term rate of replacement. In order to measure the amount of feeding and the amount of feeding, the presence of abnormality was observed by measuring the feeding amount and the feeding amount of each group at the same time every day for 28 days once the sample administration.

혈액학적 검사(Hematological values 및 CBC differentiation 측정)를 위하여 EDTA tube에 채워진 혈액은 곧바로 잘 흔들어 균등질이 되게 하고 Coulter JT(coulter electronics Inc, USA, PN 4235846B)로 WBC(White Blood Cell, 백혈구), RBC(Red Blood Cell, 적혈구), HGB(Hemoglobin, 헤모글로빈), HCT (Hematocrit, 혈액용적백분율), 혈소판(Platelet)을 측정하였다. 에탄올에 12시간 담근 후 깨끗이 세척한 slide glass에 면봉막대로 혈액을 도말하여 공기 중에서 건조한 후 Wright stain(Yong Dong pharm, Co. Kyungki, Korea)액을 10방울 떨어뜨려 3분간 고정염색하고 Wright 완충 용액(Yong Dong pharm, Co. Kyungki, Korea) 10방울로 충분히 혼합시켜 5∼6분간 염색하였다. 이때 침사가 고착하지 않도록 유의하여 검경에 불편을 최소화하였다. 이 slide glass는 spray를 사용하여 삼차증류수로 조심스럽게 수세하고 실온에서 건조하였다. 충분히 마른 후 oil immersion하에서 cover slide를 사용하지 않고 검경하였다. Manual WBC differential counter를 사용하여 백혈구를 종류별로 구별하면서 총 백혈구수 백개를 세어서 백분율로 분포를 측정하고 granularcytes는 coulter 결과와 이중확인(double check) 하였다. 망상적혈구(reticulocyte)빈도는 capillary를 사용하여 3차 증류수에 용해시켜 여과 후 실온에 보관중인 1% new methylene blue(sigma)를 혈액과 동량으로 잘 섞어 3∼5분 방치하고 깨끗이 준비된 slide glass에 도말하였다. Reticuolcyte count는 1000개의 적혈구를 계수하는 동안에 나타나는 reticulocyte의 빈도를 백분율로 나타내었다.Blood filled in the EDTA tube for hematological values (measurement of Hematological values and CBC differentiation) is well shaken and homogenized, and Coulter JT (coulter electronics Inc, USA, PN 4235846B) uses WBC (White Blood Cell), RBC (Red Blood Cell, Red Blood Cell), HGB (Hemoglobin, Hemoglobin), HCT (Hematocrit, Blood Volume Percentage), Platelets (Platelet) were measured. After soaking in ethanol for 12 hours, smear blood with a cotton swab on clean slide glass and dry it in air.10 drops of Wright stain (Yong Dong pharm, Co. Kyungki, Korea) solution is fixed and dyed for 3 minutes. (Yong Dong pharm, Co. Kyungki, Korea) 10 drops were mixed sufficiently and stained for 5-6 minutes. At this time, the discomfort in the speculum was minimized by careful not to settle the acupuncture. The slide glass was carefully washed with tertiary distilled water using a spray and dried at room temperature. After drying sufficiently, the specimen was examined without using a cover slide under oil immersion. Using the manual WBC differential counter, white blood cells were counted by type, counting the total number of white blood cells and counting the distribution as a percentage. The granularcytes were double checked with the coulter results. Reticulocyte frequency was dissolved in tertiary distilled water using capillary, filtered, and then mixed with 1% new methylene blue (sigma) stored at room temperature in the same amount with blood for 3 to 5 minutes and smeared on clean slide glass. It was. Reticuolcyte count represents the percentage of reticulocytes that appeared during counting 1000 red blood cells.

혈액생화학적 검사(총단백, 총콜레스테롤, albumin, AST, ALT, alkaline phosphatase, 총bilirubin 측정)를 위하여 EDTA freed tube에 채워진 혈액을 30분 동안 실온에 방치한 후 3000 ×g에서 15분간 원심분리 하여 얻은 혈청의 Aspartate aminotransferase(AST) 활성치는 AST kit(Boehringer Mannheim, Germany)을 사용하여 자동생화학분석기(Hitachi 747)로 측정하였다. Alanine aminotransferase(ALT)의 활성치는 ALT(Boehringer Mannheim, Germany)kit을 사용하여 자동 생화학 분석기(Hitachi 747)로 측정하였다. Total 콜레스테롤(T-Chol.)은 enzymatic coloimetric test를 이용하여 T. chol. kit(Boehringer Mannheim, Germany)를 사용하여 자동 생화학 분석기(Hitachi 747)로 측정하였다. Albumin은 pH 4.2에서 BCG(Brom Cresol-Green)과 결합하여 화합물을 형성하는데 이때의 흡광도를 ALB(Boehringer Mannheim, Germany)kit을 사용하여 자동 생화학 분석기(Hitachi 747)로 측정하였다.For blood biochemical tests (total protein, total cholesterol, albumin, AST, ALT, alkaline phosphatase, total bilirubin), the blood filled in the EDTA freed tube was left at room temperature for 30 minutes and then centrifuged at 3000 × g for 15 minutes. Aspartate aminotransferase (AST) activity of the obtained serum was measured by an automatic biochemical analyzer (Hitachi 747) using the AST kit (Boehringer Mannheim, Germany). The activity of Alanine aminotransferase (ALT) was measured by an automated biochemistry analyzer (Hitachi 747) using ALT (Boehringer Mannheim, Germany) kit. Total cholesterol (T-Chol.) Was measured by T. chol. Measurements were made with an automated biochemistry analyzer (Hitachi 747) using a kit (Boehringer Mannheim, Germany). Albumin combines with BCG (Brom Cresol-Green) to form a compound at pH 4.2. The absorbance was measured by an automatic biochemistry analyzer (Hitachi 747) using ALB (Boehringer Mannheim, Germany) kit.

Alkaline phosphatase(ALP)는 IFCC 검사 원리 하에 ALP(Boehringer Mannheim, Germany) Kit을 사용하여 자동 생화학 분석기(Hitachi 747)로 측정하였다. Total bilirubin(T-Bil.)은 DPD method 하에 Bil-T(Boehringer Mannheim, Germany) Kit을 사용하여 자동 생화학 분석기(Hitachi 747)로 측정하였다. Total protein(TP)은 Biuret method 하에 TP(Boehringer Mannheim, Germany) Kit을 사용하여 자동 생화학 분석기(Hitachi 747)를 이용하여 측정하였다.Alkaline phosphatase (ALP) was measured by an automated biochemistry analyzer (Hitachi 747) using the ALP kit (Boehringer Mannheim, Germany) under the IFCC test principle. Total bilirubin (T-Bil.) Was measured by an automated biochemistry analyzer (Hitachi 747) using Bil-T (Boehringer Mannheim, Germany) Kit under the DPD method. Total protein (TP) was measured using an automated biochemistry analyzer (Hitachi 747) using the TP kit (Boehringer Mannheim, Germany) under the Biuret method.

뇨검사(pH, 뇨잠혈, 뇨단백, 뇨당, 뇨 케톤의 측정)를 하기 위하여 부검하기 전날 각 군의 실험동물을 각각 한 마리씩 에탄올로 소독된 깔짚이 깔려있지 않은 cage에 넣고 뇨를 배출하기를 기다린 후, 배출된 뇨를 멸균된 캡 튜브에 담은 후, 지시 시험지(Serotech Korea Co. Ltd., Seoul)법을 이용하여 각각의 실험동물의 뇨pH, 뇨단백, 뇨당, 뇨케톤 및 뇨잠혈의 정도를 검사하였다.Before each autopsy for urine tests (measured pH, urine occult blood, urine protein, urine glucose, and urine ketone), one animal from each group was placed in an ethanol sterilized cage and waited for urine to be discharged. Then, the discharged urine was put in a sterile cap tube, and then the degree of urine pH, urine protein, urine glucose, urine ketone and urinary occult blood of each experimental animal was measured by using a test paper (Serotech Korea Co. Ltd., Seoul). Inspected.

사육 마지막날 동물을 overnight로 16시간 절식시키고 체중을 측정하였다. 체중 측정이 끝난 SD계의 랫트를 25㎝ 지름의 데시케이터에 넣고, 증류한 무수 에테르(T.J. Baker Analized ACS reagent, USA)로 3∼4분간 마취시킨 후 해부대에서 복부(ventral)가 보이도록 놓고 네다리를 압핀(thumb tag)으로 고정하였다. 알코올로 복부 전면을 소독한 후 forcep으로 복부피부를 집어서 해부가위로 정중선을 따라서 절제하고, 해부칼로 장기가 보이도록 절개하였다. 0.85% saline(Shinyo pure chemicals Co. LTD, Japan)으로 세척하고, 장기가 마르지 않도록 충분히 식염수를 뿌려주면서 EDTA를 처리하지 않은 주사기와 시험관을 이용하여 후대정맥에서 5∼6㎖의 혈액을 채취하여 상온에서 30분 경과 후, 3000 rpm에서 15분간 저온(4℃)원심 분리하여 혈청을 얻었다. 이는 Aspartate aminotransferase(AST), Alanine aminotransferase(ALT), alkaline phosphatase(ALP), Total 콜레스테롤, total protein, albumin, total bilirubin 분석에 사용하였다. EDTA tube에 혈액을 따로 채혈하여 얻은 EDTA 혈액을 이용하여 hematological values 및 CBC differentiation 측정에 사용하였다. 간, 신장을 차례로 절제하여 무게를 측정하고 buffered formalin용액(40% formaldehyde 10㎖, 0.65g sodium phosphate monobasic, sigma, 0.4 g sodium phosphate dibasic, sigma/100 ㎖ T.D.W)에 고정한 후 실온에 보관하였다.Animals were fasted for 16 hours overnight and weighed on the last day of breeding. SD rats weighed after weighing were placed in a 25 cm diameter desiccator, anesthetized with distilled anhydrous ether (TJ Baker Analized ACS reagent, USA) for 3 to 4 minutes, and ventral was visible from the dissection. Place and secure the four legs with thumb tags. After disinfecting the entire abdomen with alcohol, the abdominal skin was picked up with forcep, dissected along the median line with dissection scissors, and the incision was visible with an anatomical knife. Wash with 0.85% saline (Shinyo pure chemicals Co. LTD, Japan), and collect 5 ~ 6ml of blood from posterior vena cava by using syringe and test tube without EDTA while spraying saline sufficiently to prevent organs from drying out. After 30 minutes at, low-temperature (4 ℃) centrifuged for 15 minutes at 3000 rpm to obtain a serum. Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), alkaline phosphatase (ALP), total cholesterol, total protein, albumin and total bilirubin were used. EDTA blood obtained from blood collection in the EDTA tube was used to measure hematological values and CBC differentiation. Liver and kidneys were excised and weighed and fixed in buffered formalin solution (10 ml of 40% formaldehyde, 0.65 g sodium phosphate monobasic, sigma, 0.4 g sodium phosphate dibasic, sigma / 100 ml T.D.W) and stored at room temperature.

모든 실험 결과 측정치는 일변수 분석법을 사용하여 통계처리 하였으며 Student's T-test를 이용하여 p<0.05 수준에서 각 실험군 간의 유의성을 검증하였다. 모든 자료는 mean ±standard deviation으로 나타내었다.All experimental results were statistically analyzed using one-variable analysis method, and Student's T-test was used to verify the significance between each experimental group at p <0.05 level. All data are expressed as mean ± standard deviation.

시료투여 후 매일 적어도 2회 이상 실험동물의 일반상태를 세밀히 관찰하였는 바, 시료 투여기간 중 시험 물질에 기인된 특이한 이상 임상 증상은 관찰되지 않았다. 즉, 피부, 피모, 안·점막, 배변, 운동 및 패턴 등에 대하여 이상상태가 전혀 관찰되지 않았으며 상대 동물에 대한 공격성 및 자신에 대한 자해, 조직의 융해 등 이상 징후도 전혀 발견되지 않았다.The general condition of the test animals was closely observed at least twice daily after sample administration. No abnormal clinical symptoms attributable to the test substance during the sample administration were observed. In other words, no abnormalities were observed in skin, hair, eye, mucosa, bowel movement, movement and pattern, and no abnormal signs such as aggression to other animals, self-injury to oneself, and tissue fusion were found.

사육 마지막날 실험동물을 overnight로 16시간 절식시키고 에테르로 3∼4분 간 마취시킨 상태에서 부검 후 정상대조군과 각각의 실험군의 심장, 폐, 간장, 신장, 비장, 부신, 위, 정소의 이상유무를 관찰하였다. 각 실험군의 장기들은 정상대조군의 장기들과 비교하여 모양 및 형태, 크기, 색깔 등에서 전혀 외형적 이상 변화를 나타내지 않았으며 각 장기의 빛깔 및 형태가 아주 선명한 것으로 관찰되어 투여시료에 기인한 각 장기의 이상적 특이 증상은 나타나지 않는 것으로 사료되었다. 시료 투여 후 4주 동안 정상대조군 및 생맥산 추출물을 투여한 T1군의 섭이량 및 섭수량은 일정하였으며 전혀 기복을 나타내지 않았고 정상대조군과 실험군을 망라하여 사망한 실험동물은 없었다.On the last day of breeding, the animals were fasted overnight for 16 hours and anesthetized with ether for 3 to 4 minutes. After autopsy, the normal control group and each experimental group had heart, lung, liver, kidney, spleen, adrenal, stomach and testis abnormalities. Was observed. The organs of each experimental group showed no apparent abnormal change in shape, shape, size, color, etc. compared to the organs of the normal control group, and the color and shape of each organ were observed to be very clear. No ideal specific symptoms were considered. During the 4 weeks after the administration of the sample, the amount of intake and intake of the T1 group to which the normal control group and the raw machlic acid extract were administered were constant and showed no ups and downs, and there were no experimental animals that died from the normal control group and the experimental group.

실험동물 Sprague-Dawley 계 랫트(수컷)의 시료 투여 후 4주 동안의 주간 체중변화량은 정상대조군과 거의 차이를 나타내지 않았다. 시료 투여 후 4주 동안의 총 체중증가량 역시 표 9에 나타난 바와 같이 정상대조군에 비해 유의성(p<0.05)있는 차이점을 나타내지 않았다. 즉, 시료를 투여한 4주 간 실험동물의 주간 체중변화량 및 총 체중증가량은 T1이 정상군과 비슷한 수치를 보임으로써 투여시료가 체중의 증감에 특별한 영향을 미치지 않는다는 연구 결과를 나타내었다. 실험동물의 장기 중량 변화는 표 9에 나타난 바와 같다. 실험동물의 체중 당 간중량 %는 정상대조군에서 2.94 ±0.077의 수치를 나타내었는데 모든 실험군에서 유의성(p<0.05)있는 차이를 나타내지 않아 투여시료가 실험동물의 장기 중량에 특별한 영향을 나타내지 않는 결과를 보여주었다. 실험동물의 체중 당 신장중량 % 역시 0.711 ±0.043의 수치를 보인 정상대조군에 비해 모든 실험군에서 유의성(p<0.05)있는 차 이를 나타내지 않았다.The weekly weight change for 4 weeks after the administration of Sprague-Dawley rats (males) was not significantly different from that of the normal control group. The total weight gain for 4 weeks after the sample administration also showed no significant difference (p <0.05) compared to the normal control group as shown in Table 9. That is, the weekly weight change and total weight gain of the experimental animals during the four weeks of the administration of the sample showed that the T1 showed similar values to the normal group, indicating that the administration sample did not have a significant effect on the increase or decrease of the body weight. The long-term weight change of the experimental animals is shown in Table 9. The percent liver weight per body weight of the experimental animals showed a value of 2.94 ± 0.077 in the normal control group, but there was no significant difference (p <0.05) in all the experimental groups. Showed. The percent kidney weight per body weight of the experimental animals also did not show a significant difference (p <0.05) in all the experimental groups compared to the normal control group with a value of 0.711 ± 0.043.

표 9. Total body weight gains and the weight ratio of liver and kidneyTable 9. Total body weight gains and the weight ratio of liver and kidney

Group  Group Total body weight gains(g) Mean±S.D.Total body weight gains (g) Mean ± S.D. Liver (% of body weight) Mean±S.D.Liver (% of body weight) Mean ± S.D. Kidney (% of body weight) Mean±S.D.Kidney (% of body weight) Mean ± S.D. No.1 (Normal)No.1 (Normal) 120.17±7.84120.17 ± 7.84 2.94±0.0772.94 ± 0.077 0.711±0.0430.711 ± 0.043 No.2 (T1)No.2 (T1) 120.20±12.86120.20 ± 12.86 3.09±0.2793.09 ± 0.279 0.717±0.0390.717 ± 0.039

(Each value represents the mean±S.D. of 6 rats)(Each value represents the mean ± S.D. Of 6 rats)

Significant differencesas compared with control : P < 0.05Significant differencesas compared with control: P <0.05

각 군(n = 6)의 실험동물로부터 채취한 뇨에 대한 routine urinalysis 결과를 표 10에 나타내었다. 통상 검체의 뇨의 변화는 신장, 뇨로계의 병태를 잘 반영하므로 진단 예후 판정에 유용하며 아울러 체액의 변화를 잘 반영하므로 대사 장애, 당뇨병, 간질환, 전해질의 unbalance 등의 지표가 된다.Table 10 shows the routine urinalysis results for urine collected from experimental animals of each group (n = 6). In general, the change of urine in the sample reflects the condition of the kidney and urinary system well, so it is useful for the diagnosis of prognosis, and since it reflects the change of body fluid, it is an indicator of metabolic disorder, diabetes, liver disease, unbalance of electrolyte.

표 10에 나타난 정상대조군 및 실험군의 뇨 pH는 7.5 ∼ 8.5를 나타내 정상군과 실험군 사이에 별다른 차이를 나타내지 않는 것으로 나타났으며 urinalysis의 기준치에도 부합되어 투여시료에 기인한 뇨 pH의 특이 사항은 나타나지 않았다.The urine pH of the normal control group and the experimental group shown in Table 10 ranged from 7.5 to 8.5, indicating no difference between the normal group and the experimental group. The specificity of the urine pH due to the administration sample was also observed in accordance with the criteria of urinalysis. Did.

각 실험동물의 뇨단백은 urinalysis의 기준치 상 negative(-) ∼ trace(±)를 나타내는 것이 정상이나 본 실험에서는 T1군 6마리 중 1마리에서 trace, 4마리에서 1 positive 1마리에서 2 positive를 나타냈으며 정상대조군에서도 6개체중 1마리에서 trace, 3 마리에서 1 positive, 1마리에서 2 positive를 나타내는 등 거의 모든 실험동물에서 뇨단백이 검출되었다. 이와 같이 정상대조군과 실험군 모두에서 positive 한 결과가 나타난 것은 투여시료가 뇨단백 이상을 유발한 것으로는 판단할 수 없다. 통상 정상대조군의 뇨단백이 음성인데 반하여 시험군의 뇨단백이 양성으로 나타나는 경우는 투여약재에 기인한 사구체성 단백뇨, 세뇨관성 단백뇨, 신정 및 신후성단백뇨 등의 병적단백뇨를 의심할 수 있는데 반하여 정상대조군 및 시료투여군 모두에서 단백뇨가 검출될 시에는 운동성단백뇨, 기능성단백뇨 등의 생리적단백뇨(비병적단백뇨)로 판단할 수 있다. 본 실험에서 정상대조군과 실험군 모두에서 단백뇨가 검출된 것은 야행성인 랫트에서 야간에 뇨를 채취함으로 인해 활발한 운동성 생리적단백뇨가 검출된 것으로 판단되었으며 부검 후 신장에 아무런 이상징후를 발견할 수 없었던 점등도 활발한 운동으로 인해 운동성 생리적 단백뇨가 검출되었다는 판단을 뒷받침해 준다.The urinary protein of each animal was normal from negative (-) to trace (±) on the basis of urinalysis. However, in this experiment, one out of six T1 group showed traces in 1 and 4 in 1 positive and 2 in 1 positive. In the normal control group, urine protein was detected in almost all experimental animals such as traces in 1 body, 1 positive in 3, and 2 positive in 1. The positive results in both the normal control group and the experimental group could not be judged that the administration sample caused urine protein abnormality. In general, if the urine protein of the normal control group is negative while the urine protein of the test group is positive, pathological proteinuria such as glomerular proteinuria, tubuloproteinuria, kidney and renal proteinuria due to the administration drug may be suspected. When proteinuria is detected in all sample-administered groups, it can be determined as physiological proteinuria (non-pathological proteinuria) such as motor proteinuria and functional proteinuria. In this study, proteinuria was detected in both the normal control group and the experimental group. It was judged that active physiological proteinuria was detected by collecting urine at night in the nocturnal rats. Supports the determination that exercise caused physiological proteinuria.

검체의 뇨에서 당이 검출되는 것은 당뇨병, 신성당뇨, 내분비질환, 췌장질환, 간경변, 뇌종양 등의 징후를 반영하는 것이다. 표 10에 나타난 바와 같이 정상대조군 및 생맥산 추출물을 투여한 T1군 모두에서 당이 검출되지 않은 것으로 연구 결과가 나타나 투여시료에 기인한 뇨당의 이상상태는 나타나지 않는다.The detection of glucose in the urine of the sample reflects signs of diabetes mellitus, nephrotic diabetes, endocrine disease, pancreatic disease, cirrhosis and brain tumor. As shown in Table 10, no sugar was detected in both the normal control group and the T1 group to which the raw malic acid extract was administered, and the results of the study showed no abnormal state of urine glucose due to the administration sample.

표 10에 정상대조군과 실험군 각 군의 뇨 케톤 측정결과를 나타내었다. 뇨 케톤은 지방산 산화 항진 여부를 진단하는 주요 지표로써 케톤체는 생체 energy 의존도가 당질보다 지방산으로 기울 때 증가하며 이의 증가는 인슐린의 결핍을 반영한다. 따라서 검체의 뇨에서 케톤이 검출되는 것은 검체가 중증당뇨병이거나 또는 당질 섭취부족 심한 경우 기아상태에 직면해 있음을 나타낸다. 뇨 케톤에 대한 본 실험의 연구 결과에서는 정상대조군 랫트 6마리 중 2마리에서 1 positive를 나타내었으며, T1군은 1마리에서 1 positive를 나타내었다. 상기와 같이 정상대조군과 실 험군 모두에서 positive 결과가 나타난 것은 투여시료가 뇨 케톤체 이상을 유발한 것으로는 판단할 수 없다. 오히려 실험동물들이 충분한 식이를 섭취한 점과 모든 실험군에서 뇨당이 검출되지 않은 연구 결과로 미루어 볼 때 실험동물들이 섭취한 삼양사 사료의 조성(조단백 22.1% 이상, 조지방 3.5% 이상, 조섬유 5.0% 이하, 조회분 8.0% 이하 …)이 상기와 같은 결과를 초래한 것으로 판단되었다. 즉 정상대조군과 실험군의 랫트들이 섭취한 사료가 당질인 조섬유의 비율은 지극히 낮았고 상대적으로 조지방 및 조단백의 비율은 조섬유의 5, 6 배에 달할 정도로 높았기 때문에 뇨 케톤이 증가한 것으로 판단되었다. 보다 정확한 결과를 얻기 위해서는 사료를 바꾸어 섭식시킨 후 재 실험이 필요하다. 뇨잠혈은 요로의 이상을 진단하는 지표로 표 10에 정상대조군과 실험군 각 군의 뇨잠혈 측정결과를 나타내었다. 각 군모두에서 뇨잠혈이 검출되지 않았으며 따라서 투여시료에 기인한 뇨잠혈의 이상상태는 나타나지 않은 것으로 판단되었다.Table 10 shows the results of urine ketone measurement in the normal control and experimental groups. Urine ketones are a key indicator for diagnosing fatty acid hyperactivity. Ketones increase in dependence on fatty acids rather than sugars and their increase reflects insulin deficiency. Thus, the detection of ketones in the urine of a sample indicates that the sample is starved in severe diabetes or severely inadequate glucose intake. The results of this study on urine ketone showed 1 positive in 2 of 6 normal control rats and 1 positive in T1 group. As described above, the positive result in both the normal control group and the experimental group could not be judged that the administration sample caused the urine ketone body abnormality. Rather, based on the fact that the experimental animals ingested sufficient diets and no urine glucose was detected in all experimental groups, the composition of the Samyangsa diets consumed by the animals (more than 22.1% of crude protein, more than 3.5% of crude fat, less than 5.0% of crude fiber, It was judged that the inquiry content was 8.0% or less…). In other words, the ratio of crude fiber of carbohydrates in the rats of the normal control group and the experimental group was extremely low, and the ratio of crude fat and crude protein was 5, 6 times higher than that of the crude fiber. To obtain more accurate results, it is necessary to feed after changing feeds and retest. Urinary occult blood is an indicator for diagnosing urinary tract abnormalities. Table 10 shows the results of urinary occult blood in the normal control and experimental groups. Urinary occult blood was not detected in each group. Therefore, it was judged that abnormal state of urinary occult blood due to the administration sample did not appear.

표 10. Urinary analysisTable 10. Urinary analysis

pHpH Protein(U)Protein (U) Glucose(U)Glucose (U) 케톤(U)Ketone (U) Blood(U)Blood (U) No.1 (Normal)   No.1 (Normal) 7.57.5 1Positive1Positive NegativeNegative NegativeNegative Trace(±)Trace (±) 8.58.5 Trace(±)Trace (±) NegativeNegative 1Positive1Positive NegativeNegative 8.58.5 1Positive1Positive NegativeNegative NegativeNegative NegativeNegative 8.58.5 2Positive2Positive NegativeNegative 1Positive1Positive NegativeNegative 8.58.5 NegativeNegative NegativeNegative NegativeNegative 8.58.5 1Positive1Positive NegativeNegative NegativeNegative NegativeNegative No.2 (T1)   No.2 (T1) 8.08.0 2Positive2Positive NegativeNegative NegativeNegative NegativeNegative 8.58.5 1Positive1Positive NegativeNegative 1Positive1Positive NegativeNegative 8.58.5 1Positive1Positive NegativeNegative NegativeNegative NegativeNegative 8.58.5 Trace(±)Trace (±) NegativeNegative NegativeNegative NegativeNegative 8.58.5 1Positive1Positive NegativeNegative NegativeNegative NegativeNegative 8.58.5 1Positive1Positive NegativeNegative NegativeNegative NegativeNegative

±4주간 시험물질 투여 후 hematological values 및 CBC differentiation 측정 결과를 표 11에 나타내었다. 생맥산 추출물을 투여한 T1군의 RBC, WBC, HCT, HGB, PLT, Reticulocyte, WBC diff. count 수치를 Student's T-test에 의해 통계 처리한 결과, 각각의 실험군에서 미미한 차이를 나타냈지만 정상군의 그것과 비교하여 유의적인 차이(p<0.05)를 나타내는 군은 전혀 없었다. 따라서 투여시료에 기인한 혈액학적 독성은 전혀 나타나지 않은 것으로 연구결과가 나타났다.Table 11 shows the results of hematological values and CBC differentiation measurements after ± 4 weeks of administration of the test substance. RBC, WBC, HCT, HGB, PLT, Reticulocyte, WBC diff. As a result of counting statistically by Student's T-test, there was a slight difference in each experimental group, but no group showed a significant difference (p <0.05) compared to that of the normal group. Therefore, the study showed no hematologic toxicity due to the administration sample.

표 11. Hematological resultsTable 11.Hematological results

No.1 (Normal)No.1 (Normal) No.2 (T1)No.2 (T1) RBCRBC 7.86±0.137.86 ± 0.13 7.78±0.667.78 ± 0.66 WBCWBC 9.97±1.579.97 ± 1.57 9.42±2.799.42 ± 2.79 BCTBCT 47.80±3.1947.80 ± 3.19 46.20±4.4046.20 ± 4.40 HGBHGB 15.28±0.1715.28 ± 0.17 14.80±1.2714.80 ± 1.27 PLTPLT 1072±188.711072 ± 188.71 1033.40±75.671033.40 ± 75.67 RetieylocyteRetieylocyte 3.26±0.253.26 ± 0.25 3.23±0.293.23 ± 0.29 Neutrophil Stab.Neutrophil Stab. -- -- Neutrophil Seq.Neutrophil Seq. 8.60±3.388.60 ± 3.38 8.00±0.718.00 ± 0.71 LymphocyteLymphocyte 88.20±5.5688.20 ± 5.56 88.20±2.3288.20 ± 2.32 MonocyteMonocyte 3.20±2.183.20 ± 2.18 3.60±1.503.60 ± 1.50 EosinophilEosinophil -- -- BasophilBasophil -- -- NormoblastNormoblast -- -- BlastBlast -- --

(Each value represents the mean±S.D. of 6 rats)(Each value represents the mean ± S.D. Of 6 rats)

Significant differencesas compared with control : P < 0.05Significant differencesas compared with control: P <0.05

RBC, red blood cell count (104/mm3); WBC, white blood cell count (103/mm3); HCT, hematocrit (%); HGB, hemoglobin (g/dL); PLT, platelet(103/mm3)RBC, red blood cell count (10 4 / mm 3 ); WBC, white blood cell count (10 3 / mm 3 ); HCT, hematocrit (%); HGB, hemoglobin (g / dL); PLT, platelet (10 3 / mm 3 )

표 12에 4주간 시험물질 투여 후 혈액 생화학적 검사를 한 결과를 나타내었다. T1군의 TP, albumin, T-Bil, ALP, AST, ALT, T-Chol. 수치를 통계 처리한 결과, 각각의 실험군에서 미미한 차이를 나타냈지만 정상군의 그것과 비교하여 유의적인 차이(p<0.05)를 나타내는 군은 전혀 없었다. 따라서 투여시료에 기인한 혈액 생화학적 독성은 전혀 나타나지않은 것으로 판단되었다.Table 12 shows the results of blood biochemical test after administration of test substance for 4 weeks. TP, albumin, T-Bil, ALP, AST, ALT, T-Chol. As a result of statistical analysis, there was a slight difference in each experimental group, but no group showed a significant difference (p <0.05) compared to that of the normal group. Therefore, it was judged that there was no blood biochemical toxicity due to the administration sample.

표 12. Biochemical valuesTable 12. Biochemical values

No.1 (Normal)No.1 (Normal) No.2 (T1)No.2 (T1) TPTP 6.27±0.236.27 ± 0.23 6.35±0.136.35 ± 0.13 AlbuminAlbumin 3.75±0.143.75 ± 0.14 3.82±0.093.82 ± 0.09 T-Bil.T-Bil. 0.1±0.000.1 ± 0.00 0.1±0.000.1 ± 0.00 ALPALP 95.00±5.7795.00 ± 5.77 100.80±4.79100.80 ± 4.79 ASTAST 111.33±35.42111.33 ± 35.42 104.17±24.45104.17 ± 24.45 ALTALT 40.33±6.0740.33 ± 6.07 39.83±3.4839.83 ± 3.48 T-CholT-Chol 75.67±4.8275.67 ± 4.82 75.83±13.5875.83 ± 13.58

(Each value represents the mean±S.D. of 6 rats)(Each value represents the mean ± S.D. Of 6 rats)

Significant differencesas compared with control : P < 0.05Significant differencesas compared with control: P <0.05

TP, total protein (mg/dL); ALP, alkaline phosphotase (U/L);TP, total protein (mg / dL); ALP, alkaline phosphotase (U / L);

ASP, aspatate aminotransferase (U/L); ALT, alanine aminotransferase (U/L); T-Chol, totaㅣ cholesterol (U/L); T-Bil, total bilirubin (mg/dL)ASP, aspatate aminotransferase (U / L); ALT, alanine aminotransferase (U / L); T-Chol, tota cholesterol (U / L); T-Bil, total bilirubin (mg / dL)

이상에서 살펴본 바와 같이, 본 발명은 맥문동, 오미자, 인삼, 황기, 호박 등의 한약재를 복합하여 추출한 생맥산 추출물이 젖산가수분해로 항 피로효과를 나타낼 수 있으며, 혈중알코올농도를 현저히 감소시키는 알코올 분해효과가 있을 뿐만 아니라 이 생맥산 추출물로 응고시킨 두부가 고혈압이나 동맥경화증 등 심혈관계 질환 유발의 주요인자로 작용하는 혈중콜레스테롤과 중성지방의 농도를 낮추는 것을 알 수 있고, 장기 투여하였을 때 간기능 장애의 회복기능 및 각종 성인병과 노화를 방지하는 항 산화작용이 생맥산 추출물을 단독으로 투여하였을 때보다 현저히 증가함을 알 수 있으며, 이와 같은 효과를 나타낼 수 있는 약품과 기능성물질 개발에 세계적으로 많은 연구와 노력이 진행되고 있으며 특히 인체에 부작용이 적 은 천연물질로부터 위의 약재, 또는 기능성 물질을 개발할 수 있으며 신규의 항피로효과와 알코올 분해효과 및 항고지혈증 효과, 간기능활성증진, 항 산화제로서 개발할 수 있는 매우 유용한 발명이다.As described above, in the present invention, the raw malt extract, which is obtained by combining herbal medicines such as Macmundong, Schisandra chinensis, Ginseng, Astragalus, and pumpkin, may exhibit anti-fatigue effect by hydrolysis of lactic acid, and alcohol degrading effect, which significantly reduces blood alcohol concentration. In addition, the tofu coagulated with this vegetative acid extract lowers the concentrations of blood cholesterol and triglycerides, which are the main factors for cardiovascular diseases such as hypertension and arteriosclerosis. It can be seen that the function and antioxidant activity to prevent various adult diseases and aging is significantly increased than when the raw malic acid extract alone was administered, and much research and efforts around the world have been made to develop drugs and functional substances that can exhibit such effects. It is progressing, especially from natural substances with few side effects In the development of medicines, or the functional material, and is a very useful invention that can be developed as an anti-fatigue effect of the new and alcoholysis effect and anti-hyperlipemia effect and increase liver function activity, an anti-oxidant.

Claims (2)

각각 중량비율로 하여 맥문동 2.6 내지 5.0%, 오미자 2.6 내지 5.0%, 황기 2.6 내지 5.0%, 인삼 1.0 내지 5.0%, 호박 2.6 내지 5.0%와 증류수 75 내지 87%를 혼합하여 2 내지 5시간 동안 95 내지 130℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 5000∼8000×g의 속도로 10∼30분간 원심분리하여 추출하는 것을 특징으로 하는 생맥산 추출물.Each weight ratio is 2.6 to 5.0%, Mammundong 2.6 to 5.0%, Astragalus 2.6 to 5.0%, Ginseng 1.0 to 5.0%, Pumpkin 2.6 to 5.0% and distilled water 75 to 87%, 95 to 95 hours for 2 to 5 hours Raw machinate extract, characterized in that the extract is concentrated by heating in a bath at a temperature of 130 ℃, filtered with gauze, centrifuged for 10 to 30 minutes at a speed of 5000 ~ 8000 × g in a centrifuge. 각각 중량비율로 하여 맥문동 2.6 내지 5.0%, 오미자 2.6 내지 5.0%, 황기 2.6 내지 5.0%, 인삼 1.0 내지 5.0%, 호박 2.6 내지 5.0%와 증류수 75 내지 87%를 혼합하여 2 내지 5시간 동안 95 내지 130℃의 온도로 약탕기에서 가열하여 농축액을 추출하고, 거즈로 여과하여, 원심분리기에서 5000∼8000×g의 속도로 10∼30분간 원심분리하여 생맥산 추출물을 추출한 후, 콩으로 이루어진 10%(v/v) 두유액 95 ~ 97%(v/v)에 상기 생맥산 추출물을 3 ∼ 5%(v/v) 혼합하여 제조되는 것을 특징으로 하는 생맥산 추출물을 이용한 생맥산 두부.Each weight ratio is 2.6 to 5.0%, Mammundong 2.6 to 5.0%, Astragalus 2.6 to 5.0%, Ginseng 1.0 to 5.0%, Pumpkin 2.6 to 5.0% and distilled water 75 to 87%, 95 to 95 hours for 2 to 5 hours Extracted the concentrated liquid by heating in a shaker to a temperature of 130 ℃, filtered with gauze, centrifuged in a centrifuge for 10 to 30 minutes at a speed of 5000 ~ 8000 × g, and extracted with the extract of draft malt, soybean 10% (v / v) Tofu maize tofu using the saengmaek extract, characterized in that the 95% to 97% (v / v) soy milk solution is prepared by mixing the 3 to 5% (v / v).
KR1020070043556A 2007-05-04 2007-05-04 Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract KR20080098193A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070043556A KR20080098193A (en) 2007-05-04 2007-05-04 Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070043556A KR20080098193A (en) 2007-05-04 2007-05-04 Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract

Publications (1)

Publication Number Publication Date
KR20080098193A true KR20080098193A (en) 2008-11-07

Family

ID=40285768

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070043556A KR20080098193A (en) 2007-05-04 2007-05-04 Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract

Country Status (1)

Country Link
KR (1) KR20080098193A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011157340A (en) * 2010-01-28 2011-08-18 Hyuk Han Kwon Saeng-maek-san extract, saeng-maek-san tofu using the extract, and method for producing same
KR101380714B1 (en) * 2013-07-31 2014-04-09 이정규 Method for producing functional bean curd containing cultured wild ginseng

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010025732A (en) * 2001-01-22 2001-04-06 박갑주 Bean curd using mainly schizandra chinensis extract as coagulator and process for preparation thereof
KR20040017472A (en) * 2002-08-21 2004-02-27 주식회사 바이오빅스 Novel use containing coagulation of bean protein of water extracts from Schizandra chinensis and composite herb medicine
KR20040084542A (en) * 2003-03-28 2004-10-06 주식회사 바이오빅스 Bean curd for active agent of the liver function and anti-hyper plasmid lipidemia
KR100617500B1 (en) * 2000-11-08 2006-09-04 주식회사농심 Process of preparing concentrate for herb drink from herbal materials

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100617500B1 (en) * 2000-11-08 2006-09-04 주식회사농심 Process of preparing concentrate for herb drink from herbal materials
KR20010025732A (en) * 2001-01-22 2001-04-06 박갑주 Bean curd using mainly schizandra chinensis extract as coagulator and process for preparation thereof
KR20040017472A (en) * 2002-08-21 2004-02-27 주식회사 바이오빅스 Novel use containing coagulation of bean protein of water extracts from Schizandra chinensis and composite herb medicine
KR20040084542A (en) * 2003-03-28 2004-10-06 주식회사 바이오빅스 Bean curd for active agent of the liver function and anti-hyper plasmid lipidemia

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011157340A (en) * 2010-01-28 2011-08-18 Hyuk Han Kwon Saeng-maek-san extract, saeng-maek-san tofu using the extract, and method for producing same
KR101380714B1 (en) * 2013-07-31 2014-04-09 이정규 Method for producing functional bean curd containing cultured wild ginseng

Similar Documents

Publication Publication Date Title
KR20110087965A (en) Saengmaeksan extract, saengmaeksan bean curd using saengmaeksan extract and preparing method of the same
Ghasi et al. Assessment of the medical benefit in the folkloric use of Bryophyllum Pinnatum leaf among the Igbos of Nigeria for the treatment of hypertension
CN104432084B (en) A kind of conditioning powder and its production and use
Paiz et al. Glucose-lowering effect of xoconostle (Opuntia joconostle A. Web., Cactaceae) in diabetic rats
US20210046003A1 (en) Health drink composition for preventing liver damage caused by alcohol while providing excellent hangover relief
KR101371143B1 (en) Composition comprising chlorella for improving liver function or relieving hangover
Innih et al. Biochemical and Histological effects of Aqueous extract of Cyperus Esculentus in Triton Wr-1339 Induced Hyperglycemic Rats.
US20060051436A1 (en) Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling excessive calorie intake-induced disorder, and controlling agent for excessive calorie intake-induced disorder
KR101890796B1 (en) COMPOSITION FOR PREVENTING OR ALLEVIATING HANGOVER COMPRISING EXTRACTS OF GINGSENG BERRY, EXTRACTS OF Hovenia dulcis Thunberg AND MINERRAL CONCENTRATE
KR20080070182A (en) A functional soy-bean source preventing hypertension and kidney trouble and process for preparation thereof
KR20080098193A (en) Saengmaeksan extract and saengmaeksan bean curd using saengmaeksan extract
KR101511364B1 (en) Herbal Extract Composition for Prevention or Treatment of Obesity and Metabolic Syndrome Using Herbal Extract
KR101160088B1 (en) Herbal extracts composition for the prevention of alcoholic fatty liver, hyperlipidemia and hangover
KR100952188B1 (en) Health Food For The Descent Of HbA1c
KR20140137288A (en) Composition comprising an extract of Alpinia officinarum Hance for preventing and treating hangover or liver disease
KR101095834B1 (en) Natural tea composition prescribed based on patient&#39;s physical constitution
KR20040084542A (en) Bean curd for active agent of the liver function and anti-hyper plasmid lipidemia
KR20210065633A (en) Composition for improving liver injury and liver disease comprising flower of Rosa rugosa Thunberg and Cinnamomum cassia PRESL
KR20040030360A (en) Composition comprising Bando Deep Ocean Water or the concentrate thereof for treatment and prevention of liver disease
Shanmugasundaram et al. Studies on brain structure and neurological function in alcoholic rats controlled by an Indian medicinal formula (SKV)
KR20060031899A (en) 11s protein tofu and soybean embryo tofu on lipid metabolism and liver cell damage of rat
JP3587359B2 (en) A food material with blood circulation improvement action derived from purple potato
KR100892063B1 (en) The corbicula fluminea extract and a manufacturing process of ones have effict the protecting liver
KR101539057B1 (en) Beverage composition with the extract of Acer tegmentosum Maxim. for improving liver function
Obasi et al. Hepatoprotective and Nephroprotective Effects of Chrysophyllum albidum Aqueous Fresh Leaf Extract in Albino Rats

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
B601 Maintenance of original decision after re-examination before a trial
E801 Decision on dismissal of amendment
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20080819

Effective date: 20081222